<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding - Bofill Rodriguez, M - 2019 | Cochrane Library</title> <meta content="Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding - Bofill Rodriguez, M - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000400.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding - Bofill Rodriguez, M - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000400.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000400.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding" name="citation_title"/> <meta content="Magdalena Bofill Rodriguez" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Anne Lethaby" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="a.lethaby@auckland.ac.nz" name="citation_author_email"/> <meta content="Cindy Farquhar" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD000400.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/09/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000400.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000400.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000400.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; Contraceptives, Oral, Combined; Dysmenorrhea [*drug therapy]; Menorrhagia [*drug therapy]; Naproxen [therapeutic use]; Progesterone [administration &amp; dosage]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000400.pub4&amp;doi=10.1002/14651858.CD000400.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="23LRTUA6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000400\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000400\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","th","ko","ms","fa","fr","zh_HANS","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000400.pub4",title:"Non\\u2010steroidal anti\\u2010inflammatory drugs for heavy menstrual bleeding",firstPublishedDate:"Sep 19, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000400.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000400.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000400.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000400.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000400.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000400.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000400.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000400.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000400.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000400.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17058 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000400.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-abs-0007"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0160"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0050"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0051"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0056"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0057"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0087"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-sec-0149"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/appendices#CD000400-sec-0165"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/table_n/CD000400StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/table_n/CD000400StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#CD000400-cr-0002">Magdalena Bofill Rodriguez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#CD000400-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Anne Lethaby</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information#CD000400-cr-0004">Cindy Farquhar</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information/en#CD000400-sec-0174">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 September 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000400.pub4">https://doi.org/10.1002/14651858.CD000400.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000400-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000400-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000400-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000400-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000400-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000400-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD000400-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000400-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000400-abs-0001" lang="en"> <section id="CD000400-sec-0001"> <h3 class="title" id="CD000400-sec-0001">Background</h3> <p>Heavy menstrual bleeding (HMB) is an important cause of ill health in premenopausal women. Although surgery is often used as a treatment, a range of medical therapies are also available. Non‐steroidal anti‐inflammatory drugs (NSAIDs) reduce prostaglandin levels, which are elevated in women with excessive menstrual bleeding and also may have a beneficial effect on dysmenorrhoea. </p> </section> <section id="CD000400-sec-0002"> <h3 class="title" id="CD000400-sec-0002">Objectives</h3> <p>To determine the effectiveness, safety and tolerability of NSAIDs in achieving a reduction in menstrual blood loss (MBL) in women of reproductive years with HMB. </p> </section> <section id="CD000400-sec-0003"> <h3 class="title" id="CD000400-sec-0003">Search methods</h3> <p>We searched, in April 2019, the Cochrane Gynaecology and Fertility specialised register, Cochrane Central Register of Studies Online (CENTRAL CRSO), MEDLINE, Embase, PsycINFO, the clinical trial registries and reference lists of articles. </p> </section> <section id="CD000400-sec-0004"> <h3 class="title" id="CD000400-sec-0004">Selection criteria</h3> <p>The inclusion criteria were randomised comparisons of individual NSAIDs or combined with other medical therapy with each other, placebo or other medical treatments in women with regular heavy periods measured either objectively or subjectively and with no pathological or iatrogenic (treatment‐induced) causes for their HMB. </p> </section> <section id="CD000400-sec-0005"> <h3 class="title" id="CD000400-sec-0005">Data collection and analysis</h3> <p>We identified 19 randomised controlled trials (RCTs) (759 women) that fulfilled the inclusion criteria for this review and two review authors independently extracted data. We estimated odds ratios (ORs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes from the data of nine trials. We described in data tables the results of the remaining seven cross‐over trials with data unsuitable for pooling, one trial with skewed data, and one trial with missing variances. One trial had no data available for analysis. </p> </section> <section id="CD000400-sec-0006"> <h3 class="title" id="CD000400-sec-0006">Main results</h3> <p>As a group, NSAIDs were more effective than placebo at reducing HMB but less effective than tranexamic acid, danazol or the levonorgestrel‐releasing intrauterine system (LNG IUS). Treatment with danazol caused a shorter duration of menstruation and more adverse events than NSAIDs, but this did not appear to affect the acceptability of treatment, based on trials from 1980 to 1990. However, currently danazol is not a usual or recommended treatment for HMB. There was no clear evidence of difference between NSAIDs and the other treatments (oral luteal progestogen, ethamsylate, an older progesterone‐releasing intrauterine system and the oral contraceptive pill (OCP), but most studies were underpowered. There was no evidence of a difference between the individual NSAIDs (naproxen and mefenamic acid) in reducing HMB. The evidence quality ranged from low to moderate, the main limitations being risk of bias and imprecision. </p> </section> <section id="CD000400-sec-0007"> <h3 class="title" id="CD000400-sec-0007">Authors' conclusions</h3> <p>NSAIDs reduce HMB when compared with placebo, but are less effective than tranexamic acid, danazol or LNG IUS. However, adverse events are more severe with danazol therapy. In the limited number of small studies suitable for evaluation, there was no clear evidence of a difference in efficacy between NSAIDs and other medical treatments such as oral luteal progestogen, ethamsylate, OCP or the older progesterone‐releasing intrauterine system. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000400-abs-0007" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000400-abs-0007">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000400-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000400-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000400-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hu#CD000400-abs-0016">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000400-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000400-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD000400-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000400-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000400-abs-0007" lang="en"> <h3>Are non‐steroidal anti‐inflammatory drugs safe and effective for treating heavy menstrual bleeding? </h3> <p><b>Review question</b> </p> <p>Cochrane authors investigated whether non‐steroidal anti‐inflammatory drugs (NSAIDs) helped reduce heavy menstrual bleeding (HMB) in women before they reach the menopause. </p> <p><b>Background</b> </p> <p>NSAIDs reduce prostaglandin levels, which are elevated in women with excessive menstrual bleeding. It was suggested that they might help with heavy bleeding and may have a beneficial effect on painful menstrual periods. </p> <p><b>Study characteristics</b> </p> <p>Authors search medical databases and identified 19 randomised controlled trials (RCTs; clinical studies where people are randomly put into one of two or more treatment groups) with 759 women that could be included in the review, but data from only nine trials were suitable for analyses. </p> <p><b>Key results</b> </p> <p>Women sought help for HMB when it affected their quality of life. Levels of prostaglandin (a naturally occurring hormone) are higher in women with HMB and are reduced by NSAIDs. The review of trials found that NSAIDs were modestly effective in reducing HMB, but other medicines, such as danazol, tranexamic acid and levonorgestrel‐releasing intrauterine system (LNG IUS), are more effective. These results were based on a small number of low‐ to moderate‐quality trials. </p> <p><b>Quality of the evidence</b> </p> <p>The evidence quality ranged from low to moderate, the main limitations being poor reporting of study methods and imprecision resulting from small study numbers. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000400-sec-0160" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000400-sec-0160"></div> <h3 class="title" id="CD000400-sec-0161">Implications for practice</h3> <section id="CD000400-sec-0161"> <p>The review provides limited evidence of the efficacy of non‐steroidal anti‐inflammatory drugs (NSAIDs) (of which the most commonly studied is mefenamic acid (MFA)) as a treatment for reducing heavy menstrual bleeding (HMB) in women with menorrhagia. However, the efficacy of NSAIDs is superseded by danazol, tranexamic acid and levonorgestrel‐releasing levonorgestrel‐releasing (LNG IUS). Other medical treatments appear to be similarly effective compared to NSAIDs, although there is a suggestion that MFA may be more effective than either ethamsylate or oral progestogen. Danazol also reduces the number of days of menstrual bleeding but is more likely to cause adverse events when compared to NSAIDs. Gastrointestinal effects, which are often found with NSAID treatment, are less likely with MFA than naproxen. However, the benefits of NSAIDs that have been demonstrated in this review are modest; although MBL is reduced, a proportion of women will still have objective menorrhagia after treatment. </p> <p>It is important to emphasise that a proportion of women with a convincing history of menorrhagia may not have excessive bleeding as defined by the alkaline haematin method. Treatments used to reduce blood loss in these women are not likely to be as effective. </p> <p>The results of the review underscore the multiple assessments that are required in the evaluation of an optimum treatment. Efficacy is only one of these; other factors such as cost, convenience, beneficial and adverse effects on symptoms are also required. </p> </section> <h3 class="title" id="CD000400-sec-0162">Implications for research</h3> <section id="CD000400-sec-0162"> <p>Since MFA has been most commonly studied, further randomised controlled studies (RCTs) are required to compare individual NSAIDs so that the optimum treatment can be identified. </p> <p>Because many of the analyses contained only one RCT, some of the comparisons were not assessed thoroughly, in particular, the effects of NSAIDs on dysmenorrhoea, adherence to and acceptability of treatment and incidence of adverse events. However, since NSAIDs appear to be less efficacious than a number of other medical therapies, further RCTs are not likely to change the findings in this review significantly. Future studies comparing treatments for HMB should consider giving a longer duration of treatment over a number of cycles and a regimen of oral progestogen given during three of the four weeks of the cycle to assess comparative effects between medical treatments adequately. It is also possible that the addition of NSAIDs to other medical treatments may improve efficacy and further adequately designed trials are needed to explore this possibility. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000400-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000400-sec-0050"></div> <div class="table" id="CD000400-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs versus placebo (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs versus placebo (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>124 lower</b><br/> (186.36 to 61.64 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.08</b> <br/> (0.03 to 0.18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>80<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b><br/> (107 to 419) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b><br/> (107 to 419) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision (very small trial).<br/> <sup>b</sup>Downgraded one level for imprecision (single trial).<br/> <sup>c</sup>Downgraded one level for risk of bias (no explanation was provided). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs versus tranexamic acid (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus tranexamic acid (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> tranexamic acid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b><br/> alkaline haematin method </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>73 higher</b><br/> (21.66 to 124.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.44</b> <br/> (0.45 to 4.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>390 per 1000</b><br/> (167 to 672) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b><br/> (167 to 672) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 higher</b><br/> (0.47 lower to 1.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated).<br/> <sup>b</sup>Downgraded one level for imprecision (single trial). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAIDs versus ethamsylate (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus ethamsylate (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> ethamsylate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL at Rx (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL at Rx (mL/cycle) in the intervention groups was<br/> <b>42.88 lower</b><br/> (86.25 lower to 0.5 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.7</b> <br/> (0.23 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>50<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>481 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>394 per 1000</b><br/> (176 to 663) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>482 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>394 per 1000</b><br/> (176 to 664) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 lower</b><br/> (1.56 lower to 0.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio; <b>Rx:</b> treatment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated).<br/> <sup>b</sup>Downgraded one level for imprecision (one small study). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">NSAIDs versus danazol (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus danazol (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> danazol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>45.06 higher</b><br/> (18.73 to 71.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>1.03 higher</b><br/> (0.26 to 1.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">NSAIDs versus oral progestogens (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs vs oral progestogens (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> oral progestogens </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs vs oral progestogens</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>22.97 lower</b><br/> (46.57 lower to 0.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of bleeding (days) in the intervention groups was<br/> <b>0.41 lower</b><br/> (0.95 lower to 0.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">NSAIDs versus progesterone‐releasing intrauterine system (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus progesterone‐releasing intrauterine system (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> progesterone‐releasing intrauterine system </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>4 lower</b><br/> (31.23 lower to 23.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>5 lower</b><br/> (6.08 to 3.92 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (randomisation method and allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for imprecision (one small trial). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">NSAIDs versus oral contraceptive pill (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus oral contraceptive pill (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> oral contraceptive pill </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>25.25 higher</b><br/> (22.34 lower to 72.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Days of bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (randomisation method and allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for imprecision (one small study). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000400-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Mefenamic acid compared to naproxen for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Mefenamic acid compared to naproxen for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> mefenamic acid<br/> <b>Comparison:</b> naproxen </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Naproxen</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Mefenamic acid </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>21 higher</b><br/> (5.85 lower to 47.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 lower</b><br/> (1.59 lower to 0.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (lack of blinding).<br/> <sup>b</sup>Downgraded one level for imprecision (one or two small studies).<br/> <sup>c</sup>Downgraded one level for risk of bias (attrition bias). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000400-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000400-sec-0051"></div> <section id="CD000400-sec-0052"> <h3 class="title" id="CD000400-sec-0052">Description of the condition</h3> <p>Excessively heavy menstrual bleeding (menorrhagia or HMB) is an important cause of ill health in women and a very common gynaecological problem. It causes a major burden in quality of life (<a href="./references#CD000400-bbs2-0035" title="FrickKD , ClarkMA , SteinwachsDM , LangenbergP , StovallD , MunroMG , et al. Financial and quality‐of‐life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Women's Health Issues2009;19(1):70‐8. ">Frick 2009</a>), and uses substantial healthcare resources (<a href="./references#CD000400-bbs2-0045" title="LiuZ , DoanQV , BlumenthalP , DuboisRW . A systematic review evaluating health‐related quality of life, work impairment and healthcare costs and utilisation in abnormal uterine bleeding. Value in Health2007;10(8):183‐94. ">Liu 2007</a>). In the UK one in 20 women between 30 and 49 years see their doctor each year for HMB (<a href="./references#CD000400-bbs2-0050" title="National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding: assessment and management. https://www.nice.org.uk/guidance/ng88Accessed August 2019. [https://www.nice.org.uk/guidance/ng88] ">NICE 2018</a>). According to a European study, 27% of women in reproductive age had experienced HMB symptoms within the previous 12 months (<a href="./references#CD000400-bbs2-0034" title="FraserI , MansourD , BreymannC , HoffmanC et cols . Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Internationa Journal of Gynecology and Obstetrics2014;128(3):196‐200. [DOI: https://doi.org/10.1016/j.ijgo.2014.09.027] ">Fraser 2014</a>). </p> <p>HMB has often been objectively defined as 80 mL or more of menstrual blood loss (MBL) per period (<a href="./references#CD000400-bbs2-0028" title="ColeS , BillewiczW , ThomsonA . Sources of variation in menstrual blood loss. Journal of Obstetrics and Gynaecology of the British Commonwealth1971;78(10):933‐9. ">Cole 1971</a>; <a href="./references#CD000400-bbs2-0039" title="HallbergL , HogdahlAM , NilssonL , RyboG . Menstrual blood loss – a population study. Acta Obstetricia et Gynecologica Scandanavica1966;45:320‐51. ">Hallberg 1966</a>), which is unrelated to pregnancy or any known pelvic or systemic disease. However, this definition is mainly used in research and is difficult to quantify in clinical settings. Unacceptably problematic bleeding is most commonly determined by the woman herself if the amount or frequency of blood loss interferes with her physical or psychosocial well‐being. This personal perception is often what determines the need for treatment, and the assessment of outcomes afterwards. To clarify the situation, the International Federation of Gynaecology and Obstetrics (FIGO) formally defined HMB as "the woman's perspective of increased menstrual volume, regardless of regularity, frequency or duration" (<a href="./references#CD000400-bbs2-0047" title="MunroMG , CritchleyHO , BroderMS , FraserIS . FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynaecology and Obstetrics2011;113(1):3‐13. ">Munro 2011</a>). </p> <p>Research studies have traditionally used the alkaline haematin method to measure HMB objectively (<a href="./references#CD000400-bbs2-0039" title="HallbergL , HogdahlAM , NilssonL , RyboG . Menstrual blood loss – a population study. Acta Obstetricia et Gynecologica Scandanavica1966;45:320‐51. ">Hallberg 1966</a>), but a simpler method that is often used is the pictorial blood loss assessment chart (PBAC) (<a href="./references#CD000400-bbs2-0043" title="HighamJM , O'BrienPM , ShawRW . Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology1990;97:734‐39. ">Higham 1990</a>). With this method, the woman assesses the blood loss on her used sanitary pads or tampons and assigns a numerical score. It has been suggested that total menstrual fluid loss (TMFL) may be used as an assessment of HMB (<a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a>). Measurement is determined by the difference in weight of tampons or pads before and after use. TMFL correlates well with changes in objective MBL and may be of more relevance to women concerned mainly about heavy menstrual flow (flooding). </p> <p>Surgery has traditionally had a dominant role in treating HMB, but 80% of women treated by surgery have no anatomical pathology and over a third of women undergoing hysterectomy for excessive blood loss have normal uteri (wombs) removed (<a href="./references#CD000400-bbs2-0027" title="ClarkeA , BlackN , RoweP , MottS , HowieK . Indications for and outcomes of total abdominal hysterectomy for benign disease: a prospective cohort study. British Journal of Obstetrics and Gynaecology1995;102:611‐20. ">Clarke 1995</a>; <a href="./references#CD000400-bbs2-0036" title="GathD , CooperP , DayA . Hysterectomy and psychiatric disorder. Levels of psychiatric morbidity before and after hysterectomy. British Journal of Psychiatry1982;140:335‐40. ">Gath 1982</a>). Thus, medical therapy, with the avoidance of possibly unnecessary surgery and a bonus of preserved fertility in women who have not completed their family, is an attractive alternative. </p> </section> <section id="CD000400-sec-0053"> <h3 class="title" id="CD000400-sec-0053">Description of the intervention</h3> <p>A wide variety of medications are used to reduce HMB. The currently available medical therapies include hormonal agents, anti‐fibrinolytic drugs and non‐steroidal anti‐inflammatory drugs (NSAIDs). These agents vary in their effectiveness, tolerability and acceptability to women. When selecting a medical treatment, patient preference and need for contraception are issues that need to be taken into account, together with the benefits and risks of each treatment. NSAIDs are considered useful for women not desiring contraception, especially women with dysmenorrhoea (<a href="./references#CD000400-bbs2-0033" title="FraserIS , RobertJP , KouidesPA , LukesAS . A benefit‐risk review of systemic haemostatic agents. Part 2: in excessive or heavy menstrual bleeding. Drug Safety2008;31(4):275‐82. ">Fraser 2008</a>). Individual NSAIDs used for the treatment of HMB include mefenamic acid (MFA), naproxen, ibuprofen, flurbiprofen, meclofenamic acid, diclofenac, indomethacin and acetylsalicylic acid (aspirin). </p> </section> <section id="CD000400-sec-0054"> <h3 class="title" id="CD000400-sec-0054">How the intervention might work</h3> <p>A rationale for the use of NSAIDs is given by the accumulation of data suggesting a role for the prostaglandins in the pathogenesis of HMB (<a href="./references#CD000400-bbs2-0038" title="HagenfeldtK . The role of prostaglandins and allied substances in uterine haemostasis. Contraception1987;36(1):23‐35. ">Hagenfeldt 1987</a>; <a href="./references#CD000400-bbs2-0046" title="LopezBA , BuckleyS , ReesCM , MarshallJM . Meclofenamate inhibits prostaglandin E binding and adenylyl cyclase activation in human endometrium. Journal of Endocrinology1991;129(3):439‐45. ">Lopez 1991</a>). The endometria of women with excessive menstrual bleeding have higher levels of prostaglandin E2 and prostaglandin F2α when compared with women with normal menses (<a href="./references#CD000400-bbs2-0058" title="WillmanEA , CollinsWD , ClaytonSC . Studies on the involvement of prostaglandins in uterine symptomatology and pathology. British Journal of Obstetrics and Gynaecology1976;83:337‐41. ">Willman 1976</a>). There is further evidence of deranged haemostasis (abnormal clotting) as the ratio of prostaglandin E2 to F2α (<a href="./references#CD000400-bbs2-0054" title="SmithSK , AbelMH , KellyRW , BairdDT . Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1981;88:434‐42. ">Smith 1981</a>), and the ratio of prostacyclin (prostaglandin I2) to thromboxane A2 (<a href="./references#CD000400-bbs2-0012" title="MakarainenL , YlikorkalaO . Primary and myoma‐associated menorrhagia: role of prostaglandin and effects of ibuprofen. British Journal of Obstetrics and Gynaecology1986;93:974‐8. ">Makarainen 1986</a>), are elevated. These substances are present both in the endometrium and myometrium, although the exact mechanism by which the excessive blood loss occurs remains speculative. NSAIDs reduce prostaglandin levels by inhibiting the cyclo‐oxygenase enzyme (<a href="./references#CD000400-bbs2-0051" title="ReesMC , DiMarzoV , TippinsJR , MorrisHR , TurnbullAC . Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. Journal of Endocrinology1987;113:291‐5. ">Rees 1987</a>; <a href="./references#CD000400-bbs2-0054" title="SmithSK , AbelMH , KellyRW , BairdDT . Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1981;88:434‐42. ">Smith 1981</a>). </p> <p>NSAIDs are contraindicated in women with HMB and an underlying bleeding disorder because of their inhibitory effect on platelet (cell fragment) aggregation (<a href="./references#CD000400-bbs2-0044" title="KadirRA , LukesAS , KouidesPA , FernandezH , GoudemandJ . Management of excessive menstrual bleeding in women with hemostatic disorders. Fertility and Sterility2005;84(5):1352‐9. ">Kadir 2005</a>). </p> </section> <section id="CD000400-sec-0055"> <h3 class="title" id="CD000400-sec-0055">Why it is important to do this review</h3> <p>NSAIDs reduces MBL by 25% to 35% or more in about three‐quarters of women with HMB (<a href="./references#CD000400-bbs2-0053" title="RoySN , BhattacharyaS . Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Safety2004;27(2):75‐90. ">Roy 2004</a>). NSAIDs also can have a beneficial effect on dysmenorrhoea, a symptom often related to HMB. Adverse effects of treatment, especially gastrointestinal effects, are variable in frequency but are not usually severe. It is important to distinguish this medical option for HMB from other options with respect to effectiveness, tolerability, acceptability and safety for women to make informed choices. In addition, it is usually assumed that there are no differences in effectiveness between individual NSAIDs, even though there are individual women who seem to respond well to one agent but less well to another. This review tested this assumption with the inclusion of individual NSAID comparisons for the treatment of HMB. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000400-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000400-sec-0056"></div> <p>To determine the effectiveness, safety and tolerability of NSAIDs in achieving a reduction in MBL in women of reproductive years with HMB. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000400-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000400-sec-0057"></div> <section id="CD000400-sec-0058"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000400-sec-0059"> <h4 class="title">Types of studies</h4> <p>Randomised controlled comparisons of NSAID therapies or combined NSAID and other medical therapy with either placebo or other medical therapies when used to reduce HMB. Comparisons of one type of NSAID with another type of NSAID were also eligible for the review. </p> </section> <section id="CD000400-sec-0060"> <h4 class="title">Types of participants</h4> <section id="CD000400-sec-0061"> <h5 class="title">Inclusion criteria</h5> <p> <ul id="CD000400-list-0001"> <li> <p>Women of reproductive years.</p> </li> <li> <p>Women with regular heavy periods measured either objectively (greater than 80 mL) for one or more cycles prior to the intervention or subjectively by the women (this criterion has been changed from two or more previous cycles to one or more previous cycles in the 2007 and 2012 updates). </p> </li> <li> <p>Women recruited from primary care, family planning or specialist clinics.</p> </li> </ul> </p> </section> <section id="CD000400-sec-0062"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD000400-list-0002"> <li> <p>Postmenopausal bleeding (less than one year from the last period).</p> </li> <li> <p>Irregular menses and intermenstrual bleeding.</p> </li> <li> <p>Pathological causes of HMB.</p> </li> <li> <p>Iatrogenic (treatment induced) causes of HMB.</p> </li> </ul> </p> </section> </section> <section id="CD000400-sec-0063"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD000400-list-0003"> <li> <p>NSAIDs versus placebo or any other medical therapy (antifibrinolytic agents, hormone treatment, danazol, gonadotropin‐releasing hormone analogues). </p> </li> <li> <p>Specific NSAIDs versus other NSAIDs (MFA, naproxen, ibuprofen, flurbiprofen, meclofenamic acid, diclofenac, acetylsalicylic acid). </p> </li> <li> <p>NSAIDs combined with other medical treatment(s) versus other medical treatment(s) (this comparison was added in the 2012 update). </p> </li> </ul> </p> <p>We considered variable doses and routes of administration of treatments.</p> </section> <section id="CD000400-sec-0064"> <h4 class="title">Types of outcome measures</h4> <p>Each of the following outcomes were recorded where available.</p> <section id="CD000400-sec-0065"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD000400-list-0004"> <li> <p>MBL:</p> <ul id="CD000400-list-0005"> <li> <p>objective assessment of blood loss, by the alkaline haematin method (mL/cycle) (<a href="./references#CD000400-bbs2-0048" title="NewtonJ , BarnardG , CollinsW . A rapid method for measuring menstrual blood loss using automatic extraction. Contraception1977;16:269‐82. ">Newton 1977</a>); </p> </li> <li> <p>subjective assessment of blood loss by the pictorial chart method (score on PBAC chart) (<a href="./references#CD000400-bbs2-0043" title="HighamJM , O'BrienPM , ShawRW . Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology1990;97:734‐39. ">Higham 1990</a>), or patient perception (on questionnaire or survey instrument). </p> </li> </ul> </li> <li> <p>Quality of life: women's perceived change in quality of life where it was recorded in a reproducible and validated format. This included improvement in symptoms of dysmenorrhoea, headache, diarrhoea, depression and other menstrually related symptoms. </p> </li> </ul> </p> </section> <section id="CD000400-sec-0066"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000400-list-0006"> <li> <p>Total menstrual fluid loss (TMFL: measured as difference between the original weight of the sanitary material and the returned sanitary material) (<a href="./references#CD000400-bbs2-0031" title="FraserIS , McCarronG , MarkhamR , RestaT . Blood and total fluid content of menstrual discharge. Obstetrics &amp; Gynecology1985;65:194‐8. ">Fraser 1985</a>; <a href="./references#CD000400-bbs2-0032" title="FraserIS , WarnerP , MarantosPA . Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstetrics &amp; Gynecology2001;98:806‐14. ">Fraser 2001</a>). </p> </li> <li> <p>Number of days' bleeding during the intervention menstrual cycle.</p> </li> <li> <p>Patient adherence to treatment.</p> </li> <li> <p>Patient acceptability of treatment.</p> </li> <li> <p>Adverse events, of any degree, reported either spontaneously by the patient or elicited from specific questioning. </p> </li> <li> <p>Resource use/cost.</p> </li> </ul> </p> </section> </section> </section> <section id="CD000400-sec-0067"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD000400-sec-0068"> <h4 class="title">Electronic searches</h4> <p>The original search was performed in 1998, with updated searches undertaken in September/October 2001, April 2004, July 2007, July 2012 and April 2019. We searched the following electronic databases, trial registers and websites: </p> <p> <ul id="CD000400-list-0007"> <li> <p>Cochrane Gynaecology and Fertility Specialised Register of Controlled Trials; PROCITE platform (searched 1 April 2019) </p> </li> <li> <p>Cochrane Central Register of Studies Online (CENTRAL CRSO); web platform (searched 1 April 2019) </p> </li> <li> <p>MEDLINE; OVID platform (searched from 1946 to 1 April 2019)</p> </li> <li> <p>Embase; OVID platform (searched from 1980 to 1 April 2019)</p> </li> <li> <p>PsycINFO; OVID platform (searched from 1806 to 1 April 2019)</p> </li> <li> <p>trial registers for ongoing and registered trials: <a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>, <a href="http://clinicaltrials.gov/ct/home" target="_blank">clinicaltrials.gov/ct/home</a>, <a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch/Default.aspx</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>conference abstracts in the ISI Web of Knowledge: <a href="http://wokinfo.com/" target="_blank">wokinfo.com/</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>LILACS database: <a href="http://lilacs.bvsalud.org/en/" target="_blank">lilacs.bvsalud.org/en/</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>clinical study results for clinical trial results of marketed pharmaceuticals: <a href="http://www.clinicalstudyresults.org/" target="_blank">www.clinicalstudyresults.org/</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>PubMed: <a href="http://www.ncbi.nlm.nih.gov/pubmed/" target="_blank">www.ncbi.nlm.nih.gov/pubmed/</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>OpenSIGLE database: <a href="http://opensigle.inist.fr" target="_blank">opensigle.inist.fr</a>; web platform (searched 1 April 2019) </p> </li> <li> <p>GOOGLE and GOOGLE Scholar for grey literature, web platform (searched 1 April 2019).</p> </li> </ul> </p> </section> <section id="CD000400-sec-0069"> <h4 class="title">Searching other resources</h4> <p>We also searched the reference lists of relevant publications and identified trials.</p> </section> </section> <section id="CD000400-sec-0070"> <h3 class="title" id="CD000400-sec-0070">Data collection and analysis</h3> <section id="CD000400-sec-0071"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AL and MB) independently selected trials for inclusion in the review using the search strategy described previously. We used the prespecified inclusion criteria to consider titles and abstracts from the lists of potentially relevant studies. Where necessary, we obtained full‐text copies of the studies for the independent assessment. We planned to resolve differences in opinion over study selection by discussion and consensus, but this did not prove necessary. </p> </section> <section id="CD000400-sec-0072"> <h4 class="title">Data extraction and management</h4> <p>We analysed included trials for the following quality criteria, methodological details and study characteristics. </p> <section id="CD000400-sec-0073"> <h5 class="title">Trial characteristics</h5> <p> <ul id="CD000400-list-0008"> <li> <p>Method of randomisation.</p> </li> <li> <p>Presence or absence of blinding to treatment allocation.</p> </li> <li> <p>Quality of allocation concealment.</p> </li> <li> <p>Number of women randomised, excluded or lost to follow‐up.</p> </li> <li> <p>Use of an intention‐to‐treat analysis.</p> </li> <li> <p>Use of a power calculation.</p> </li> <li> <p>Duration, timing and location of the study.</p> </li> </ul> </p> </section> <section id="CD000400-sec-0074"> <h5 class="title">Characteristics of the study participants</h5> <p> <ul id="CD000400-list-0009"> <li> <p>Age and any other recorded characteristics of women in the study.</p> </li> <li> <p>Methods used to define heavy MBL.</p> </li> <li> <p>Other inclusion criteria.</p> </li> <li> <p>Exclusion criteria.</p> </li> </ul> </p> </section> <section id="CD000400-sec-0075"> <h5 class="title">Interventions used</h5> <p> <ul id="CD000400-list-0010"> <li> <p>Types of medical therapy used.</p> </li> <li> <p>Dose, duration and timing of administration of medical therapy.</p> </li> </ul> </p> </section> <section id="CD000400-sec-0076"> <h5 class="title">Outcomes</h5> <p> <ul id="CD000400-list-0011"> <li> <p>Methods used to measure MBL at or after intervention.</p> </li> <li> <p>Methods used to evaluate patient satisfaction, symptoms and change in quality of life.</p> </li> </ul> </p> <p>All three review authors independently extracted data using forms designed according to Cochrane guidelines. One of these review authors was a content expert and the other two had methodological expertise. Where necessary, we sought additional information on trial methodology or actual trial data from the principal author of any trials that appeared to meet the eligibility criteria. In cases where results were presented in graphs and no actual data were given, we extracted the data from the graphs. </p> </section> </section> <section id="CD000400-sec-0077"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AL and either CA or SF) independently assessed the included studies for risk of bias using the Cochrane 'Risk of bias' assessment tool (<a href="./references#CD000400-bbs2-0042" title="HigginsJP , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. ">Higgins 2011</a>). Individual domains included random sequence generation, allocation concealment, blinding, incomplete outcome data and other bias; each domain was separately scored as low, unclear or high risk of bias. </p> <p>We resolved disagreements over quality assessments by discussion with a third review author (KD). </p> </section> <section id="CD000400-sec-0078"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. proportion of women who found the treatment unacceptable), we expressed results for each study as an odds ratio (OR) with 95% confidence intervals (CI) and combined them for meta‐analysis with Review Manager 5 using the Peto OR (<a href="./references#CD000400-bbs2-0052" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). For all dichotomous outcomes, a high value had negative consequences (e.g. the proportion of women who had no subjective improvement in MBL and proportion who had no improvement in quality of life). For ease of interpretation of the graphs, this meant that results to the left of the line favoured the experimental group (i.e. NSAIDs), and results to the right of the line favoured the control or other comparison group. </p> <p>There were difficulties with the reporting of continuous outcomes (e.g. MBL after treatment). Meta‐analysis with Review Manager 5 software used a mean difference (MD) to combine outcomes and required data to be presented as absolute values of post‐treatment means with their standard deviations (SD) (or change values (either absolute or percentage) between baseline and final values together with the SD of the change). For many outcomes, particularly MBL, the data are skewed and authors correctly presented their data as medians with a range. Where possible, we obtained original data from the principal authors, but post‐treatment means and SDs were not always available or calculable. Where only medians and ranges were available and there was evidence that the data were approximately normally distributed, we regarded the median as being identical to the mean and calculated an estimate of the SD from the range (range multiplied by 0.95/4). We performed sensitivity analysis with and without these studies in the meta‐analysis to check the appropriateness of this assumption. Where there was strong evidence that the data were highly skewed and the sample size was small, we considered it inappropriate to regard the median as identical to the mean and did not combine the results of the relevant study in meta‐analysis but reported them separately in the 'Other data' section of this review. For all continuous outcomes, a high value had negative consequences and so results to the left of the line in the graphs favoured the experimental group (i.e. NSAIDs), and results to the right of the line favoured the control or other comparison group. </p> </section> <section id="CD000400-sec-0079"> <h4 class="title">Unit of analysis issues</h4> <p>All analyses were per woman randomised.</p> </section> <section id="CD000400-sec-0080"> <h4 class="title">Dealing with missing data</h4> <p>We analysed data, where possible, on an intention‐to‐treat basis. We attempted to obtain missing data from the authors of the included studies, where necessary, but were often unsuccessful. We did not impute missing values. </p> </section> <section id="CD000400-sec-0081"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a clinically meaningful summary. Where meta‐analysis was feasible, we examined heterogeneity between the results of different combined studies by inspecting the scatter in the data points and the overlap in their CIs. We then assessed any outliers identified by this method to determine whether the differences could be further explained. We used the results of the Chi<sup>2</sup> tests for formal assessment of heterogeneity (with P &lt; 0.10 being considered evidence of significant heterogeneity) and the I<sup>2</sup> statistic for quantity (<a href="./references#CD000400-bbs2-0041" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD000400-sec-0082"> <h4 class="title">Assessment of reporting biases</h4> <p>We undertook a comprehensive search to minimise the chance of publication bias in the review. We planned to use a funnel plot to explore the possibility of small‐study effects on the results, but there were insufficient studies for this to be meaningful. </p> </section> <section id="CD000400-sec-0083"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analysis where possible (participants, interventions, outcomes and duration of included studies sufficiently homogeneous, or where data were in an appropriate form for combination, or both). Where there was substantial heterogeneity indicated that could not be explained, we used a random‐effects model as a more appropriate method for estimating a mean treatment effect. </p> <p>Several studies were cross‐over in design. In principle, cross‐over and parallel group designed RCTs estimate the same effect but there are practical difficulties, such as carryover from the first treatment period and differences in the standard errors, and so pooling the data from both types of trials was not appropriate. An option was to enter data from cross‐over trials at the end of the first treatment period so that the two comparison groups were in effect parallel groups. We attempted to locate the original data at the end of the first cross‐over trial period but for most of the cross‐over trials these were unavailable. The data from these trials were described in text form in the 'Other data' section of this review and not included in the meta‐analysis. </p> </section> <section id="CD000400-sec-0084"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Differences between the action of individual NSAIDs are minimal but there is considerable variation in individual patient response and in the incidence and type of adverse events. We performed subgroup analyses comparing the efficacy and adverse events of individual NSAIDs with placebo and compared the results. </p> </section> <section id="CD000400-sec-0085"> <h4 class="title">Sensitivity analysis</h4> <p>We planned sensitivity analysis to compare potential differences in participants, interventions, outcomes and whether allocation concealment was adequate in the included studies. However, only limited sensitivity analysis could be undertaken because of the small numbers of included studies for each outcome. </p> <section id="CD000400-sec-0086"> <h5 class="title">Overall quality of the body of evidence; 'Summary of findings' tables</h5> <p>We generated 'Summary of findings' tables using GRADEpro software (<a href="./references#CD000400-bbs2-0037" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed April 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2014. ">GRADEpro GDT</a>) to evaluate the overall quality of the body of evidence for both the primary review outcomes: MBL and quality of life. Two review authors (AL, KD) independently judged on the overall quality of studies for each of these outcomes, according to the GRADE criteria (study limitations, i.e. risk of bias; consistency of effect; imprecision; indirectness and publication bias). For each GRADE criterion, if there were concerns about quality, the assessment could be downgraded by one or two levels. Overall quality for each outcome could be categorised as high, moderate, low or very low according to these assessments. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000400-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000400-sec-0087"></div> <section id="CD000400-sec-0088"> <h3 class="title">Description of studies</h3> <section id="CD000400-sec-0089"> <h4 class="title">Results of the search</h4> <p>The search identified 25 RCTs of medical treatment with NSAIDs for regular HMB. Nineteen RCTs met the criteria for inclusion in the review (see <a href="./references#CD000400-sec-0181" title="">Characteristics of included studies</a> table). See <a href="#CD000400-fig-0001">Figure 1</a> for details of the screening and selection process. </p> <div class="figure" id="CD000400-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD000400-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD000400-sec-0090"> <h4 class="title">Included studies</h4> <p>The studies included 759 women but not all the women could be included in each measured outcome as there were multiple comparison groups. One study that was previously awaiting classification was included on the 2019 update, but had no data available for comparisons (<a href="./references#CD000400-bbs2-0011" title="JaisamrarnJ , SitavarinS , SuwikromS , KamolpornwijitW . Randomized trial of medical therapies for menorrhagia: clinical efficacy and effect on quality of life. XVIII FIGO World Congress of Gynecology and Obstetrics2006;3:83. ">Jaisamrarn 2006</a>). We contacted the authors but received no data. Thirteen studies were conducted in Europe. Six in the UK (<a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a>; <a href="./references#CD000400-bbs2-0004" title="CameronIT , HainingR , LumsdenMA , ThomasVR , SmithSK . The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics &amp; Gynecology1990;76:85‐8. SmithSK , HainingRH , Reed‐ThomasV , CameronIT . The diagnosis and treatment of menorrhagia. Silver Jubilee British Congress of Obstetrics and Gynaecology; 1989 Jul 4‐7; London (UK)1989:62. ">Cameron 1990</a>; <a href="./references#CD000400-bbs2-0005" title="ChamberlainG . Comparing treatments for menorrhagia. Nursing Times1992;88:46. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1991;98:707‐11. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . Raw data from RCT. Lorex Synthélabo Laboratory, UK. ">Chamberlain 1991</a>; <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a>; <a href="./references#CD000400-bbs2-0013" title="MuggeridgeJ , ElderMG . Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums1983;5:83‐8. ">Muggeridge 1983</a>; <a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a>), two in Ireland (<a href="./references#CD000400-bbs2-0002" title="BonnarJ , SheppardBL . Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ1996;313:579‐82. ">Bonnar 1996</a>; <a href="./references#CD000400-bbs2-0006" title="DockerayCJ , SheppardBL , BonnarJ . Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology1989;96:840‐4. ">Dockeray 1989</a>), two in Finland (<a href="./references#CD000400-bbs2-0012" title="MakarainenL , YlikorkalaO . Primary and myoma‐associated menorrhagia: role of prostaglandin and effects of ibuprofen. British Journal of Obstetrics and Gynaecology1986;93:974‐8. ">Makarainen 1986</a>; <a href="./references#CD000400-bbs2-0019" title="YlikorkalaO , PekonenF . Naproxen reduces idiopathic but not fibromyoma‐induced menorrhagia. Obstetrics &amp; Gynaecology1986;68:10‐2. ">Ylikorkala 1986</a>), two in Sweden (<a href="./references#CD000400-bbs2-0001" title="AnderschB , MilsomI , RyboG . An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica1988;67:645‐8. MilsomI , AnderssonK , AnderschB , RyboG . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel‐releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology1991;164:879‐83. ">Andersch 1988</a>; <a href="./references#CD000400-bbs2-0016" title="NygrenKG , RyboG . Prostaglandins and menorrhagia. Acta Obstetricia et Gynecologica Scandinavica Supplement1983;113:101‐3. RyboG , NilssonS , SikstromB , NygrenKG . Naproxen in menorrhagia (letter). Lancet1981;March:608‐9. ">Rybo 1981</a>), and one in the Netherlands (<a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a>). Two studies were conducted in India (<a href="./references#CD000400-bbs2-0009" title="GroverV , UshaR , GuptaU , KalraS . Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia‐Oceania Journal of Obstetrics &amp; Gynaecology1990;16:255‐9. ">Grover 1990</a>; <a href="./references#CD000400-bbs2-0014" title="NajamR , AgarwaldD , TyagiR , SinghS . Comparison of tranexamic acid with a combination of tranexamic acid and mefenamic acid in reducing menstrual blood loss in ovulatory dysfunctional uterine bleeding. Journal of Clinical and Diagnostic Research2010;4:3020‐5. ">Najam 2010</a>), two in Australia (<a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a>; <a href="./references#CD000400-bbs2-0008" title="FraserIS , McCarronG . Randomised trial of 2 hormonal and 2 prostaglandin‐inhibiting agents in women with a complaint of menorrhagia. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1991;31(1):66‐70. ">Fraser 1991</a>), one in Thailand (<a href="./references#CD000400-bbs2-0011" title="JaisamrarnJ , SitavarinS , SuwikromS , KamolpornwijitW . Randomized trial of medical therapies for menorrhagia: clinical efficacy and effect on quality of life. XVIII FIGO World Congress of Gynecology and Obstetrics2006;3:83. ">Jaisamrarn 2006</a>), and one in Canada (<a href="./references#CD000400-bbs2-0017" title="TsangBK , DomingoMT , SpenceJE , GarnerPR , DudleyDK , OxornH . Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo . Canadian Journal of Physiology and Pharmacology1987;65:2081‐4. ">Tsang 1987</a>). </p> <section id="CD000400-sec-0091"> <h5 class="title">Trials included in the meta‐analysis</h5> <p>The data from nine trials with 419 women were included in meta‐analyses (<a href="./references#CD000400-bbs2-0002" title="BonnarJ , SheppardBL . Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ1996;313:579‐82. ">Bonnar 1996</a>; <a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a>; <a href="./references#CD000400-bbs2-0004" title="CameronIT , HainingR , LumsdenMA , ThomasVR , SmithSK . The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics &amp; Gynecology1990;76:85‐8. SmithSK , HainingRH , Reed‐ThomasV , CameronIT . The diagnosis and treatment of menorrhagia. Silver Jubilee British Congress of Obstetrics and Gynaecology; 1989 Jul 4‐7; London (UK)1989:62. ">Cameron 1990</a>; <a href="./references#CD000400-bbs2-0005" title="ChamberlainG . Comparing treatments for menorrhagia. Nursing Times1992;88:46. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1991;98:707‐11. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . Raw data from RCT. Lorex Synthélabo Laboratory, UK. ">Chamberlain 1991</a>; <a href="./references#CD000400-bbs2-0006" title="DockerayCJ , SheppardBL , BonnarJ . Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology1989;96:840‐4. ">Dockeray 1989</a>; <a href="./references#CD000400-bbs2-0008" title="FraserIS , McCarronG . Randomised trial of 2 hormonal and 2 prostaglandin‐inhibiting agents in women with a complaint of menorrhagia. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1991;31(1):66‐70. ">Fraser 1991</a>; <a href="./references#CD000400-bbs2-0009" title="GroverV , UshaR , GuptaU , KalraS . Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia‐Oceania Journal of Obstetrics &amp; Gynaecology1990;16:255‐9. ">Grover 1990</a>; <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a>; <a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a>). All comparisons were between MFA and placebo (two trials); another NSAID; naproxen (two trials) or other medical treatments: danazol, tranexamic acid, ethamsylate, oral contraceptive pill (OCP), norethisterone given during the luteal phase and the progesterone‐releasing intrauterine system (IUS). </p> <section id="CD000400-sec-0092"> <h6 class="title">Participants</h6> <p>The age of the participants in 18 of the included trials ranged from 18 to 55 years and all had sought medical assistance for HMB. One trial included women from 12 to 45 years, with 67% being over 30 years, but no further details were provided.Ten studies defined HMB objectively using the alkaline haematin method to satisfy the criteria for inclusion. Some of the studies also required the women to have regular ovulatory cycles. Common exclusion criteria were hormonal contraception, intrauterine device (IUD) use, fibroids and pelvic pathology. </p> </section> <section id="CD000400-sec-0093"> <h6 class="title">Interventions</h6> <p>In general, the dosage regimen did not vary extensively for each type of NSAID. MFA was most commonly studied and the usual dosage was 500 mg three times a day from onset of menses for four or five days or until menstruation ceased. Two studies required administration of MFA four or five days prior to menses until its cessation (<a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a>; <a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a>), and one study used a slightly different dosage (500 mg initially, then 250 mg four times per day for three to five days) (<a href="./references#CD000400-bbs2-0017" title="TsangBK , DomingoMT , SpenceJE , GarnerPR , DudleyDK , OxornH . Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo . Canadian Journal of Physiology and Pharmacology1987;65:2081‐4. ">Tsang 1987</a>). Four studies used a similar regimen for naproxen: 500 mg at onset and three to five hours later, then 500 mg twice a day for five days (<a href="./references#CD000400-bbs2-0019" title="YlikorkalaO , PekonenF . Naproxen reduces idiopathic but not fibromyoma‐induced menorrhagia. Obstetrics &amp; Gynaecology1986;68:10‐2. ">Ylikorkala 1986</a>); 500 mg in the morning, 250 mg in the afternoon for days one to two, then 250 mg twice a day for up to seven days (<a href="./references#CD000400-bbs2-0016" title="NygrenKG , RyboG . Prostaglandins and menorrhagia. Acta Obstetricia et Gynecologica Scandinavica Supplement1983;113:101‐3. RyboG , NilssonS , SikstromB , NygrenKG . Naproxen in menorrhagia (letter). Lancet1981;March:608‐9. ">Rybo 1981</a>); 500 mg then 250 mg three to four times daily (<a href="./references#CD000400-bbs2-0008" title="FraserIS , McCarronG . Randomised trial of 2 hormonal and 2 prostaglandin‐inhibiting agents in women with a complaint of menorrhagia. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1991;31(1):66‐70. ">Fraser 1991</a>); 550 mg initially, then 275 mg four times daily for five days (<a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a>). The trial that compared MBL in women treated with ibuprofen versus placebo used two different regimens of ibuprofen: 600 mg daily and 1200 mg daily. </p> </section> <section id="CD000400-sec-0094"> <h6 class="title">Comparisons</h6> <p>The duration of medication with tranexamic acid and ethamsylate was during the five days of menstruation. Danazol administration was daily throughout the cycle. The studies gave oral progestogen as a luteal phase supplement although a longer regimen is widely accepted as having greater efficacy. The progesterone‐releasing IUS/levonorgestrel‐releasing IUS (LNG IUS) were inserted for the whole trial period and the OCP taken for three of the four weeks of the cycle. Duration of the intervention mostly ranged from two to three menstrual cycles, but for the <a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a> the treatment phase was only one month. </p> </section> <section id="CD000400-sec-0095"> <h6 class="title">Outcomes</h6> <p>All trials but two, had MBL measured objectively by the alkaline haematin method as the main outcome; the remaining trials assessed the effect of treatment on MBL by the proportion of women experiencing "relief" of HMB (no details given by the author as to how this was measured) (<a href="./references#CD000400-bbs2-0009" title="GroverV , UshaR , GuptaU , KalraS . Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia‐Oceania Journal of Obstetrics &amp; Gynaecology1990;16:255‐9. ">Grover 1990</a>), or PBAC scores (<a href="./references#CD000400-bbs2-0014" title="NajamR , AgarwaldD , TyagiR , SinghS . Comparison of tranexamic acid with a combination of tranexamic acid and mefenamic acid in reducing menstrual blood loss in ovulatory dysfunctional uterine bleeding. Journal of Clinical and Diagnostic Research2010;4:3020‐5. ">Najam 2010</a>). One trial also measured TMFL and PBAC scores in addition to MBL measured by the alkaline haematin method. Five trials assessed the effects of treatment on number of days of menstrual bleeding, eight trials measured the incidence of adverse events, three trials measured the effects on dysmenorrhoea, two assessed treatment acceptability and women's perception of change in MBL, and one trial measured non‐adherence. </p> <p>Trials used several methods to assess adverse events. Some studies recorded the numbers of women who experienced any adverse events. Other studies reported the numbers of women who experienced specific adverse events (e.g. headache, nausea, abdominal pain). One study attempted to combine specific adverse events in broad categories (e.g. gastrointestinal events and central nervous system events). The patient either mentioned adverse effects spontaneously or by responding to specific questioning such as "Do you think the treatment has upset you in any way?" </p> </section> </section> <section id="CD000400-sec-0096"> <h5 class="title">Data considered unsuitable for pooling in the meta‐analysis (cross<i>‐</i>over trials, trials with skewed data or no measure of variance) </h5> <p>The data from seven trials of cross‐over design with 99 women could not be pooled and included in the meta‐analysis but the individual results are described in data tables rather than forest plots (<a href="./references#CD000400-bbs2-0001" title="AnderschB , MilsomI , RyboG . An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica1988;67:645‐8. MilsomI , AnderssonK , AnderschB , RyboG . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel‐releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology1991;164:879‐83. ">Andersch 1988</a>; <a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a>; <a href="./references#CD000400-bbs2-0012" title="MakarainenL , YlikorkalaO . Primary and myoma‐associated menorrhagia: role of prostaglandin and effects of ibuprofen. British Journal of Obstetrics and Gynaecology1986;93:974‐8. ">Makarainen 1986</a>; <a href="./references#CD000400-bbs2-0013" title="MuggeridgeJ , ElderMG . Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums1983;5:83‐8. ">Muggeridge 1983</a>; <a href="./references#CD000400-bbs2-0016" title="NygrenKG , RyboG . Prostaglandins and menorrhagia. Acta Obstetricia et Gynecologica Scandinavica Supplement1983;113:101‐3. RyboG , NilssonS , SikstromB , NygrenKG . Naproxen in menorrhagia (letter). Lancet1981;March:608‐9. ">Rybo 1981</a>; <a href="./references#CD000400-bbs2-0017" title="TsangBK , DomingoMT , SpenceJE , GarnerPR , DudleyDK , OxornH . Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo . Canadian Journal of Physiology and Pharmacology1987;65:2081‐4. ">Tsang 1987</a>; <a href="./references#CD000400-bbs2-0019" title="YlikorkalaO , PekonenF . Naproxen reduces idiopathic but not fibromyoma‐induced menorrhagia. Obstetrics &amp; Gynaecology1986;68:10‐2. ">Ylikorkala 1986</a>). Three trials compared MBL in MFA and placebo groups, two trials compared MBL in naproxen and placebo groups, one trial compared MBL in ibuprofen and placebo groups (<a href="./references#CD000400-fig-0007" title="">Analysis 1.4</a>), and one trial compared MBL in flurbiprofen and tranexamic acid treatment groups (<a href="./references#CD000400-fig-0013" title="">Analysis 2.6</a>). </p> <p>The data from <a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a> were highly skewed and the results from this study are also reported in data tables (<a href="./references#CD000400-fig-0033" title="">Analysis 6.2</a>). </p> <p>The data from <a href="./references#CD000400-bbs2-0014" title="NajamR , AgarwaldD , TyagiR , SinghS . Comparison of tranexamic acid with a combination of tranexamic acid and mefenamic acid in reducing menstrual blood loss in ovulatory dysfunctional uterine bleeding. Journal of Clinical and Diagnostic Research2010;4:3020‐5. ">Najam 2010</a> did not include measures of the variance and the results of this study are also reported in data tables (<a href="./references#CD000400-fig-0042" title="">Analysis 9.1</a>). </p> </section> </section> <section id="CD000400-sec-0097"> <h4 class="title">Excluded studies</h4> <p>Two trials were excluded in previous versions of the review. One of these assessed reduction in bleeding in the treatment and placebo groups according to the number of sanitary pads used compared to the baseline use of sanitary wear in the categories of no change, one to three less, four to six less and seven to nine less) (<a href="./references#CD000400-bbs2-0022" title="Martinez AlcalaFO , Casanova AlvarezN , Manzanilla SevillaR , Gonzalez IniguezR , Martinez ReyesYP . Efficacy and tolerability of mefenamic acid in dysfunctional uterine bleeding [Eficacia y tolerabilidad del acido mefenamico en la hipermenorrea disfuncional]. La Prensa Médica Mexicana1979;44(11‐12):295‐8. ">Martinez Alcala 1979</a>). There is sometimes a weak positive correlation between the number of pads and tampons used and the amount of MBL, but this is often dependent on the personal hygiene of the woman and varies even between a woman's two menstruations of almost the same volume (<a href="./references#CD000400-bbs2-0026" title="ChimbiraTH , AndersonAB , TurnbullAC . Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. British Journal of Obstetrics and Gynaecology1980;87:603‐9. ">Chimbira 1980</a>; <a href="./references#CD000400-bbs2-0030" title="FraserIS , McCarronG , MarkhamR . A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics and Gynecology1984;149:788‐93. ">Fraser 1984</a>). The other excluded trial compared meclofenamate sodium with placebo (<a href="./references#CD000400-bbs2-0024" title="VargyasJM , CampeauJD , MishellDR . Treatment of menorrhagia with meclofenamate sodium. American Journal of Obstetrics &amp; Gynecology1987;157:944‐50. ">Vargyas 1987</a>). It included seven women (21%) with fitted IUDs, which is an exclusion criterion for this review. </p> <p>In the 2019 version, we excluded three trials. Two because the women were randomised to "medical treatment" including NSAIDs. <a href="./references#CD000400-bbs2-0021" title="GuptaJ , KaiJ , MiddletonL , PattisonH , GrayR , DanielsJ . Levonorgestrel intrauterine system versus medical therapy for menorrhagia. New England Journal of Medicine2013;368:128‐37. [CRSREF: 3289371] ">Gupta 2013</a> randomised women to the progesterone‐releasing IUS or to other medical treatment including NSAIDs, but they were free to choose the medical treatment. <a href="./references#CD000400-bbs2-0020" title="FamuyideA , Laughlin‐TommasoS , ShazlyS , Hall LongK , BreitkopfD , WeaverA . Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): a clinical and economic analysis. PloS One2017;12(11):e0188176. [DOI: 10.1371/journal.pone.0188176] ">Famuyide 2017</a> randomised women to endometrial ablation or medical treatment, and they were also free to choose between combined OCP or NSAIDs. We excluded one trial because the comparison was MFA versus MFA plus herbal medicine (<a href="./references#CD000400-bbs2-0023" title="NaafeM , KarimanN , KeshavarzZ , KhademiN , MojabF , MohammadbeigiA . Effect of hydroalcoholic extracts of capsella bursa‐pastoris on heavy menstrual bleeding: a randomized clinical trial. Journal of Alternative and Complementary Medicine2018;24(7):694‐700. ">Naafe 2018</a>). </p> </section> </section> <section id="CD000400-sec-0098"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias assessments are presented for the individual studies in the <a href="./references#CD000400-sec-0181" title="">Characteristics of included studies</a> table and summaries are presented in figures (<a href="#CD000400-fig-0002">Figure 2</a>; <a href="#CD000400-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD000400-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000400-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000400-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000400-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000400-sec-0099"> <h4 class="title">Allocation</h4> <section id="CD000400-sec-0100"> <h5 class="title">Sequence generation and allocation concealment</h5> <p>Eight studies described an adequate randomisation method and were at low risk of bias for this domain; the remaining 11 studies did not report how this was performed and were classified at unclear risk of bias. Only two of the 19 trials were at low risk of bias for allocation concealment (<a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a>; <a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a>). However, <a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a> had a very small sample size, had a high proportion of withdrawals and duration of treatment was for only one month. The remaining trials were at unclear risk of bias as they did not provide evidence of sufficient safeguards in place to conceal the allocation. </p> </section> </section> <section id="CD000400-sec-0101"> <h4 class="title">Blinding</h4> <p>Ten of 19 studies used double blinding (low risk of bias) and one trial used single blinding (unclear who was blinded; unclear risk); the remaining studies did not report whether blinding was undertaken and this was considered unlikely (high risk of bias). </p> </section> <section id="CD000400-sec-0102"> <h4 class="title">Incomplete outcome data</h4> <p>Nine of 19 trials did not report whether there was any loss to follow‐up or exclusions or withdrawals post randomisation. The remaining 10 trials had loss to follow‐up ranging from 16% to 29% (three trials) or exclusions or withdrawals after randomisation ranging from 3% to 42% (seven trials) (low risk of bias). Two of these trials with exclusions or withdrawals had intention‐to‐treat analysis and were considered at low risk of bias. </p> </section> <section id="CD000400-sec-0103"> <h4 class="title">Other potential sources of bias</h4> <p>Two trials reported results separately for subgroups. One trial gave results for four women with primary menorrhagia out of the total 14 who were randomised (<a href="./references#CD000400-bbs2-0016" title="NygrenKG , RyboG . Prostaglandins and menorrhagia. Acta Obstetricia et Gynecologica Scandinavica Supplement1983;113:101‐3. RyboG , NilssonS , SikstromB , NygrenKG . Naproxen in menorrhagia (letter). Lancet1981;March:608‐9. ">Rybo 1981</a>). Another study included a heterogeneous group of women with many different diagnoses: ovulatory and anovulatory menorrhagia, fibroids, IUD, tubal sterilisation, von Willebrand's disease and OCP (<a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a>). Reduction in blood loss was reported separately for the women with ovulatory menorrhagia but a significant proportion of this group did not have excessive bleeding, as defined by the alkaline haematin method. This subgroup of women did not report other outcomes. </p> <p>Two trials provided confusing outcome data and were at high risk of this bias. Fourteen trials provided insufficient information and were considered at unclear risk of this bias. Three trials reported similar data at baseline and were at low risk of this bias. </p> </section> </section> <section id="CD000400-sec-0104"> <h3 class="title" id="CD000400-sec-0104">Effects of interventions</h3> <p>See: <a href="./full#CD000400-tbl-0001"><b>Summary of findings for the main comparison</b> NSAIDs versus placebo (control)</a>; <a href="./full#CD000400-tbl-0002"><b>Summary of findings 2</b> NSAIDs versus tranexamic acid (control)</a>; <a href="./full#CD000400-tbl-0003"><b>Summary of findings 3</b> NSAIDs versus ethamsylate (control)</a>; <a href="./full#CD000400-tbl-0004"><b>Summary of findings 4</b> NSAIDs versus danazol (control)</a>; <a href="./full#CD000400-tbl-0005"><b>Summary of findings 5</b> NSAIDs versus oral progestogens (control)</a>; <a href="./full#CD000400-tbl-0006"><b>Summary of findings 6</b> NSAIDs versus progesterone‐releasing intrauterine system (control)</a>; <a href="./full#CD000400-tbl-0007"><b>Summary of findings 7</b> NSAIDs versus oral contraceptive pill (control)</a>; <a href="./full#CD000400-tbl-0008"><b>Summary of findings 8</b> Mefenamic acid compared to naproxen for heavy menstrual bleeding</a> </p> <section id="CD000400-sec-0105"> <h4 class="title">1 NSAIDs versus placebo</h4> <p><a href="./full#CD000400-tbl-0001">summary of findings Table for the main comparison</a> provides a summary of the main findings for the comparison of NSAIDs versus placebo. </p> <section id="CD000400-sec-0106"> <h5 class="title">1.1 Menstrual blood loss (objective, subjective or both)</h5> <p>Eight trials measured MBL in different ways. One small trial with 11 women found clear evidence of difference in mean MBL favouring the MFA group compared to the placebo group (MBL in the MFA group was 124 mL less than in the placebo group; MD –124 mL/cycle, 95% CI –186 to –62; <a href="./references#CD000400-fig-0004" title="">Analysis 1.1</a>). There were no other trials with data suitable for pooling but six cross‐over trials reported a total effect at the end of the study (three trials compared MFA with placebo, two trials compared naproxen with placebo and one trial compared different dosages (600 mg and 1200 mg daily) of ibuprofen with placebo). In five of the seven post‐treatment comparisons, there was clear evidence of difference in the post‐treatment mean MBL favouring NSAIDs. However, there was no clear evidence of difference between low‐dose ibuprofen versus placebo (<a href="./references#CD000400-bbs2-0012" title="MakarainenL , YlikorkalaO . Primary and myoma‐associated menorrhagia: role of prostaglandin and effects of ibuprofen. British Journal of Obstetrics and Gynaecology1986;93:974‐8. ">Makarainen 1986</a>), or MFA versus placebo (<a href="./references#CD000400-bbs2-0013" title="MuggeridgeJ , ElderMG . Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums1983;5:83‐8. ">Muggeridge 1983</a>). </p> <p>There was clear evidence of a difference in women's perception of "relief" of HMB between MFA and placebo groups (OR 0.08, 95% CI 0.03 to 0.18; <a href="./references#CD000400-fig-0005" title="">Analysis 1.2</a>; <a href="./references#CD000400-bbs2-0009" title="GroverV , UshaR , GuptaU , KalraS . Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia‐Oceania Journal of Obstetrics &amp; Gynaecology1990;16:255‐9. ">Grover 1990</a>). The authors provided no additional information regarding the measurement of relief of HMB. In one of the cross‐over trials not included in the meta‐analysis (<a href="./references#CD000400-bbs2-0019" title="YlikorkalaO , PekonenF . Naproxen reduces idiopathic but not fibromyoma‐induced menorrhagia. Obstetrics &amp; Gynaecology1986;68:10‐2. ">Ylikorkala 1986</a>), 79% of women indicated that naproxen was "better" compared to 21% who indicated that the placebo treatment was "better" at reducing their HMB. </p> </section> <section id="CD000400-sec-0107"> <h5 class="title">1.2 Adverse events</h5> <p>In the small van Eijkeren and colleagues study, total incidence of adverse events was comparable between MFA and placebo (<a href="./references#CD000400-fig-0006" title="">Analysis 1.3</a>; <a href="./references#CD000400-bbs2-0018" title="vanEijkerenMA , ChristiaensGC , GeuzeHJ , HaspelsAA , SixmaJJ . Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology1992;166:1419‐28. ">van Eijkeren 1992</a>). Of the cross‐over trials identified above, there was no change in dysmenorrhoea scores between MFA and placebo (<a href="./references#CD000400-bbs2-0013" title="MuggeridgeJ , ElderMG . Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums1983;5:83‐8. ">Muggeridge 1983</a>), and no differences in the total incidence of adverse events between naproxen versus placebo and ibuprofen versus placebo (<a href="./references#CD000400-fig-0007" title="">Analysis 1.4</a>; <a href="./references#CD000400-bbs2-0012" title="MakarainenL , YlikorkalaO . Primary and myoma‐associated menorrhagia: role of prostaglandin and effects of ibuprofen. British Journal of Obstetrics and Gynaecology1986;93:974‐8. ">Makarainen 1986</a>; <a href="./references#CD000400-bbs2-0019" title="YlikorkalaO , PekonenF . Naproxen reduces idiopathic but not fibromyoma‐induced menorrhagia. Obstetrics &amp; Gynaecology1986;68:10‐2. ">Ylikorkala 1986</a>). </p> </section> <section id="CD000400-sec-0108"> <h5 class="title">1.3 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess quality of life, TMFL, number of days of bleeding, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0109"> <h4 class="title">2 NSAIDs versus tranexamic acid</h4> <p><a href="./full#CD000400-tbl-0002">summary of findings Table 2</a> provides a summary of the main findings for the comparison of NSAIDS versus tranexamic acid. </p> <section id="CD000400-sec-0110"> <h5 class="title">2.1 Menstrual blood loss (objective, subjective or both)</h5> <p>In the one study available for analysis with 48 women, the MD was 73 mL/cycle (95% CI 22 to 124) in the comparison of MFA and tranexamic acid (MBL in the tranexamic acid group was 73 mL less than in the MFA group; <a href="./references#CD000400-fig-0008" title="">Analysis 2.1</a>; <a href="./references#CD000400-bbs2-0002" title="BonnarJ , SheppardBL . Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ1996;313:579‐82. ">Bonnar 1996</a>). In the same study, there was no clear evidence of difference between the groups in the women's perception of change in their MBL (<a href="./references#CD000400-fig-0009" title="">Analysis 2.2</a>; <a href="./references#CD000400-bbs2-0002" title="BonnarJ , SheppardBL . Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ1996;313:579‐82. ">Bonnar 1996</a>). In one cross‐over trial, where data were not suitable for pooling, mean MBL was significantly less in the tranexamic acid cycles (155 mL) than in the flurbiprofen cycles (223 mL) (P &lt; 0.01; <a href="./references#CD000400-bbs2-0001" title="AnderschB , MilsomI , RyboG . An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica1988;67:645‐8. MilsomI , AnderssonK , AnderschB , RyboG . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel‐releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology1991;164:879‐83. ">Andersch 1988</a>). </p> </section> <section id="CD000400-sec-0111"> <h5 class="title">2.2 Number of days' bleeding</h5> <p>In the one study available for analysis, there was no clear evidence of a difference between treatment groups (Peto OR 1.44, 95% CI 0.45 to 4.61; 49 women; 1 study; <a href="./references#CD000400-fig-0010" title="">Analysis 2.3</a>). </p> </section> <section id="CD000400-sec-0112"> <h5 class="title">2.3 Quality of life</h5> <p>There was no clear evidence of differences between groups for change in quality of life (Peto OR 1.13, 95% CI 0.27 to 4.73; 49 women; 1 study; <a href="./references#CD000400-fig-0011" title="">Analysis 2.4</a>) and treatment acceptability (Peto OR 1.17, 95% CI 0.32 to 4.27; 49 women; 1 study; <a href="./references#CD000400-fig-0012" title="">Analysis 2.5</a>), although these results were based on only one study. Another study reported outcomes in a form that was not suitable for analysis (<a href="./references#CD000400-fig-0013" title="">Analysis 2.6</a>). </p> </section> <section id="CD000400-sec-0113"> <h5 class="title">2.4 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess TMFL, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0114"> <h4 class="title">3 NSAIDs versus ethamsylate</h4> <p><a href="./full#CD000400-tbl-0003">summary of findings Table 3</a> provides a summary of the main findings for the comparison of NSAIDs versus ethamsylate. </p> <p>Two studies contributed to this comparison (<a href="./references#CD000400-bbs2-0002" title="BonnarJ , SheppardBL . Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ1996;313:579‐82. ">Bonnar 1996</a>; <a href="./references#CD000400-bbs2-0005" title="ChamberlainG . Comparing treatments for menorrhagia. Nursing Times1992;88:46. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1991;98:707‐11. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . Raw data from RCT. Lorex Synthélabo Laboratory, UK. ">Chamberlain 1991</a>). </p> <section id="CD000400-sec-0115"> <h5 class="title">3.1 Menstrual blood loss (objective, subjective or both)</h5> <p>There was no evidence of a difference in MBL measured objectively both immediately after treatment in two studies (MD –42.88 mL/cycle, 95% CI –86.25 to 0.50; 82 women; I<sup>2</sup> = 0%; <a href="./references#CD000400-fig-0014" title="">Analysis 3.1</a>), or at longer follow‐up at six months in one study (MD –70.30 mL/cycle, 95% CI –158.88 to 18.28; 31 women; <a href="./references#CD000400-fig-0015" title="">Analysis 3.2</a>). Women were unable to perceive a difference in their blood loss in one study (Peto OR 0.70, 95% CI 0.23 to 2.12; 50 women; <a href="./references#CD000400-fig-0016" title="">Analysis 3.3</a>). </p> </section> <section id="CD000400-sec-0116"> <h5 class="title">3.2 Quality of life</h5> <p>In the one study available for analysis, there was no clear evidence of a difference between treatment groups for quality of life (Peto OR 0.83, 95% CI 0.18 to 3.72; 50 women; <a href="./references#CD000400-fig-0017" title="">Analysis 3.4</a>). </p> </section> <section id="CD000400-sec-0117"> <h5 class="title">3.3 Number of days' bleeding</h5> <p>There was no clear evidence of a difference in number of treatment days of menstrual bleeding between treatment groups in one study (MD –0.40 days, 95% CI –1.56 to 0.76; 46 women; <a href="./references#CD000400-fig-0018" title="">Analysis 3.5</a>). </p> </section> <section id="CD000400-sec-0118"> <h5 class="title">3.4 Patient acceptability of treatment</h5> <p>A greater proportion of women found ethamsylate unacceptable compared to NSAIDs (Peto OR 0.20, 95% CI 0.07 to 0.61; 50 women; <a href="./references#CD000400-fig-0019" title="">Analysis 3.6</a>). </p> </section> <section id="CD000400-sec-0119"> <h5 class="title">3.5 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess TMFL, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0120"> <h4 class="title">4 NSAIDs versus danazol</h4> <p><a href="./full#CD000400-tbl-0004">summary of findings Table 4</a> provides a summary of the main findings for the comparison of NSAIDs versus danazol. </p> <section id="CD000400-sec-0121"> <h5 class="title">4.1 Menstrual blood loss (objective)</h5> <p>Reduction of HMB was significantly greater in the danazol group (MD 45.06 mL/cycle, 95% CI 18.73 to 71.39; 79 women; 3 studies; I<sup>2</sup> = 29%; <a href="./references#CD000400-fig-0020" title="">Analysis 4.1</a>). No trials assessed women's perception of MBL after treatment. </p> </section> <section id="CD000400-sec-0122"> <h5 class="title">4.2 Quality of life</h5> <p>There was no clear evidence of a difference between groups for quality of life (Peto OR 1.19, 95% CI 0.20 to 7.05; 28 women; 1 study; <a href="./references#CD000400-fig-0021" title="">Analysis 4.2</a>). </p> </section> <section id="CD000400-sec-0123"> <h5 class="title">4.3 Number of days' bleeding</h5> <p>There was clear evidence of a difference in the number of days of menstrual bleeding between danazol and the MFA groups favouring danazol (MD 1.03 days, 95% CI 0.26 to 1.80; 53 women; 2 studies; I<sup>2</sup> = 0%; <a href="./references#CD000400-fig-0022" title="">Analysis 4.3</a>). </p> </section> <section id="CD000400-sec-0124"> <h5 class="title">4.4 Patient acceptability of treatment</h5> <p>There was no clear evidence of a difference between groups for treatment acceptability, although these results were based on one study with 40 women (Peto OR 0.82, 95% CI 0.24 to 2.80; <a href="./references#CD000400-fig-0023" title="">Analysis 4.4</a>) </p> </section> <section id="CD000400-sec-0125"> <h5 class="title">4.5 Adverse events</h5> <p>In this same study, the risk of adverse events was less in the MFA group (Peto OR 0.17, 95% CI 0.05 to 0.59; 40 women; <a href="./references#CD000400-fig-0024" title="">Analysis 4.5</a>). </p> </section> <section id="CD000400-sec-0126"> <h5 class="title">4.6 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess TMFL, patient adherence to treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0127"> <h4 class="title">5 NSAIDs versus oral progestogen (luteal phase)</h4> <p><a href="./full#CD000400-tbl-0005">summary of findings Table 5</a> provides a summary of the main findings for the comparison of NSAIDs versus oral progestogen. </p> <section id="CD000400-sec-0128"> <h5 class="title">5.1 Menstrual blood loss (objective, subjective or both)</h5> <p>Two studies assessed MBL and duration of bleeding.</p> <p>NSAIDs may have improved MBL compared to oral progestogens (MD –22.97 mL/cycle, 95% CI –46.57 to 0.62; 48 women; 2 studies; I<sup>2</sup> = 71%; <a href="./references#CD000400-fig-0025" title="">Analysis 5.1</a>). The high heterogeneity could be explained by different inclusion criteria (age and bleeding level at baseline) in the two included studies. </p> </section> <section id="CD000400-sec-0129"> <h5 class="title">5.2 Number of days' bleeding</h5> <p>There was no clear evidence of a difference in duration of bleeding (MD –0.41, 95% CI –0.95 to 0.13; 48 women; 2 studies; I<sup>2</sup> = 35%; <a href="./references#CD000400-fig-0026" title="">Analysis 5.2</a>). </p> </section> <section id="CD000400-sec-0130"> <h5 class="title">5.3 Adverse events</h5> <p>There was no clear evidence of a difference for non‐adherence (Peto OR 0.88, 95% CI 0.05 to 14.78; 32 women; 1 study; <a href="./references#CD000400-fig-0027" title="">Analysis 5.3</a>), total adverse events (Peto OR 0.54, 95% CI 0.13 to 2.26; 32 women; 1 study; <a href="./references#CD000400-fig-0028" title="">Analysis 5.4</a>), headache (Peto OR 0.63, 95% CI 0.14 to 2.86; 32 women; 1 study; <a href="./references#CD000400-fig-0029" title="">Analysis 5.5</a>), abdominal pain (Peto OR 0.86, 95% CI 0.15 to 4.96; 32 women; 1 study; <a href="./references#CD000400-fig-0030" title="">Analysis 5.6</a>), and nausea (Peto OR 1.79, 95% CI 0.17 to 18.65; 32 women; 1 study; <a href="./references#CD000400-fig-0031" title="">Analysis 5.7</a>). One study had no data available for comparisons (<a href="./references#CD000400-bbs2-0011" title="JaisamrarnJ , SitavarinS , SuwikromS , KamolpornwijitW . Randomized trial of medical therapies for menorrhagia: clinical efficacy and effect on quality of life. XVIII FIGO World Congress of Gynecology and Obstetrics2006;3:83. ">Jaisamrarn 2006</a>). </p> </section> <section id="CD000400-sec-0131"> <h5 class="title">5.4 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess TMFL, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0132"> <h4 class="title">6 NSAIDs versus progesterone‐releasing intrauterine system</h4> <p><a href="./full#CD000400-tbl-0006">summary of findings Table 6</a> provides a summary of the main findings for the comparison of NSAIDs versus progesterone‐releasing IUS. </p> <section id="CD000400-sec-0133"> <h5 class="title">6.1 Menstrual blood loss (objective, subjective or both)</h5> <p>There was no clear evidence of a difference in reduction of HMB between groups (MD –4.00 mL/cycle, 95% CI –31.23 to 23.23; 16 women; 1 study; <a href="./references#CD000400-fig-0032" title="">Analysis 6.1</a>). Another larger trial that compared MFA with the LNG IUS reported highly significant differences between groups in MBL and PBAC scores (P &lt; 0.001 for both outcomes; no summary effect measures calculated; <a href="./references#CD000400-fig-0033" title="">Analysis 6.2</a>). </p> </section> <section id="CD000400-sec-0134"> <h5 class="title">6.2 Total menstrual fluid loss</h5> <p>One trial that compared MFA with the LNG IUS reported highly significant differences between groups in TMFL (P &lt; 0.001; no summary effect measures calculated; <a href="./references#CD000400-fig-0033" title="">Analysis 6.2</a>). </p> </section> <section id="CD000400-sec-0135"> <h5 class="title">6.3 Number of days' bleeding</h5> <p>There was clear evidence of a difference in the number of days of menstrual bleeding favouring NSAIDs compared to the progesterone‐releasing IUS (withdrawn from the market since 2001) (MD –5.00 days, 95% CI –6.08 to –3.92; 16 women; 1 study; <a href="./references#CD000400-fig-0034" title="">Analysis 6.3</a>). </p> </section> <section id="CD000400-sec-0136"> <h5 class="title">6.4 Adverse events</h5> <p>There was no clear evidence of a difference for adverse events other than abdominal pain which may have been lower (Peto OR 0.22, 95% CI 0.06 to 0.87; 51 women; 1 study; <a href="./references#CD000400-fig-0035" title="">Analysis 6.4</a>). </p> </section> <section id="CD000400-sec-0137"> <h5 class="title">6.5 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess quality of life, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0138"> <h4 class="title">7 NSAIDs versus oral contraceptive pill</h4> <p><a href="./full#CD000400-tbl-0007">summary of findings Table 7</a> provides a summary of the main findings for the comparison of NSAIDs versus OCP. </p> <section id="CD000400-sec-0139"> <h5 class="title">7.1 Menstrual blood loss (objective, subjective or both)</h5> <p>In the one study with data suitable for analysis, there was no clear evidence of a difference in the objective measurement of MBL between groups (MD 25.25 mL/cycle, 95% CI –22.34 to 72.84; 26 women; 1 study; <a href="./references#CD000400-fig-0036" title="">Analysis 7.1</a>). </p> </section> <section id="CD000400-sec-0140"> <h5 class="title">7.2 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess quality of life, TMFL, number of days' bleeding, patient adherence to treatment, patient acceptability of treatment, adverse events or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0141"> <h4 class="title">8 Mefenamic acid versus naproxen</h4> <p><a href="./full#CD000400-tbl-0008">summary of findings Table 8</a> provides a summary of the main findings for the comparison of MFA versus naproxen. </p> <section id="CD000400-sec-0142"> <h5 class="title">8.1 Menstrual blood loss (objective, subjective or both)</h5> <p>There was no clear evidence of a difference between groups in the objective measurement of MBL (MD 21.00 mL/cycle, 95% CI –5.85 to 47.85; 61 women; 2 studies; I<sup>2</sup> = 25%; <a href="./references#CD000400-fig-0037" title="">Analysis 8.1</a>). </p> </section> <section id="CD000400-sec-0143"> <h5 class="title">8.2 Number of days' bleeding</h5> <p>There was no clear evidence of a difference between groups in duration of bleeding (MD –0.40 days, 95% CI –1.59 to 0.79; 35 women; 1 study; <a href="./references#CD000400-fig-0038" title="">Analysis 8.2</a>). </p> </section> <section id="CD000400-sec-0144"> <h5 class="title">8.3 Adverse events</h5> <p>There was no clear evidence of difference in the total incidence of adverse events between groups (Peto OR 0.12, 95% CI 0.01 to 2.00; 35 women; 1 study; <a href="./references#CD000400-fig-0039" title="">Analysis 8.3</a>). </p> <p>There was clear evidence of a difference in the risk of gastrointestinal effects favouring the MFA group compared with the naproxen group (Peto OR 0.24, 95% CI 0.06 to 0.87; 35 women; 1 study; <a href="./references#CD000400-fig-0040" title="">Analysis 8.4</a>). </p> <p>There was no clear evidence of a difference in central nervous system adverse events between groups (Peto OR 1.40, 95% CI 0.34 to 5.73; 35 women; 1 study; <a href="./references#CD000400-fig-0041" title="">Analysis 8.5</a>). </p> </section> <section id="CD000400-sec-0145"> <h5 class="title">8.4 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess quality of life, TMFL, number of days' bleeding, patient adherence to treatment, patient acceptability of treatment or resource use/cost. </p> </section> </section> <section id="CD000400-sec-0146"> <h4 class="title">9 Tranexamic acid plus mefenamic acid versus tranexamic acid</h4> <section id="CD000400-sec-0147"> <h5 class="title">9.1 Menstrual blood loss (objective, subjective or both)</h5> <p>There was clear evidence of a reduction in MBL from baseline in the combined tranexamic acid plus MFA group in one study with 55 women (PBAC score at baseline 246 versus PBAC score at 6 months' follow‐up 100; P &lt; 0.01). There was no clear evidence of a difference in MBL from baseline in the tranexamic acid alone group (PBAC score at baseline 250 versus PBAC score at 6 months' follow‐up 125; P &gt; 0.05; <a href="./references#CD000400-fig-0042" title="">Analysis 9.1</a>). </p> </section> <section id="CD000400-sec-0148"> <h5 class="title">9.2 Other outcomes</h5> <p>We identified no trials for the meta‐analysis to assess quality of life, TMFL, number of days' bleeding, patient adherence to treatment, patient acceptability of treatment, adverse events or resource use/cost. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000400-sec-0149" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000400-sec-0149"></div> <section id="CD000400-sec-0150"> <h3 class="title" id="CD000400-sec-0150">Summary of main results</h3> <section id="CD000400-sec-0151"> <h4 class="title">NSAIDs versus placebo</h4> <p>Evidence from the one trial in the meta‐analysis and five of the six cross‐over studies confirms that NSAIDs are more effective than placebo in reducing MBL. However, the quality of the only study in the meta‐analysis was not high; 42% of randomised patients dropped out and the analysis was not intention to treat. A highly significant difference between NSAIDs and placebo in reduction of MBL was also perceived by the patients in one study that recorded the proportion of patients who were relieved of their HMB as the primary outcome. </p> </section> <section id="CD000400-sec-0152"> <h4 class="title">NSAIDs versus other medical treatments</h4> <p>In the comparisons of NSAIDs as a group with other medical treatments, both tranexamic acid and danazol were more effective than any of the NSAIDs in reducing MBL. One cross‐over trial confirmed results from the only study in the meta‐analysis assessing the effect NSAIDs versus tranexamic acid on MBL (<a href="./references#CD000400-bbs2-0001" title="AnderschB , MilsomI , RyboG . An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica1988;67:645‐8. MilsomI , AnderssonK , AnderschB , RyboG . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel‐releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology1991;164:879‐83. ">Andersch 1988</a>). There was clear evidence of a difference in the reduction of blood loss in the meta‐analysis of NSAIDs versus danazol in two included studies; the third study had non‐comparable groups at baseline with a significantly higher (almost double) pretreatment MBL in the danazol group and the results must be regarded with caution (<a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a>). </p> <p>There was no clear evidence of a difference in reduction of MBL in the comparisons of NSAIDs with ethamsylate, oral progestogen given during the luteal phase, the progesterone‐releasing IUS and the OCP. </p> <p>The study comparing the progesterone‐releasing IUS was very small and results may have been affected by the lack of baseline comparability between groups. The progesterone‐releasing IUS was withdrawn from the market in 2001. A newer progesterone‐releasing IUS delivering 20 μg of levonorgestrel daily was developed primarily as a contraceptive and reduced both MBL and TMFL more effectively in one study (<a href="./references#CD000400-bbs2-0015" title="ReidPC , Virtanen‐KariS . Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. British Journal of Obstetrics and Gynaecology2005;112:1121‐5. ">Reid 2005</a>). There is evidence that blood contributes only a third of the TMFL in normal women (<a href="./references#CD000400-bbs2-0031" title="FraserIS , McCarronG , MarkhamR , RestaT . Blood and total fluid content of menstrual discharge. Obstetrics &amp; Gynecology1985;65:194‐8. ">Fraser 1985</a>; <a href="./references#CD000400-bbs2-0032" title="FraserIS , WarnerP , MarantosPA . Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstetrics &amp; Gynecology2001;98:806‐14. ">Fraser 2001</a>). Thus, it could be argued that women may seek medical advice for excess total fluid loss (i.e. blood and fluid) rather than blood loss per se. The study found high correlations between MBL and TMFL and the authors suggested that TMFL may be a more useful estimate of MBL because it is easier to measure. It remains to be demonstrated in future trials if women are more concerned about the volume rather than the composition of unacceptable menstrual loss. </p> <p>In the comparisons of NSAIDs with other medical treatment, the number of days of menstrual bleeding was shorter with danazol treatment and longer with the progesterone‐releasing IUS, although this latter result was based on only one small trial. This outcome was not compared with OCP treatment. </p> <p>Abdominal pain was more likely with LNG IUS than MFA in the short term (up to six months) but this adverse effect usually resolved over time (<a href="./references#CD000400-bbs2-0055" title="StewartA , CumminsC , GoldL , JordanR , PhillipsW . The effectiveness of the levonorgestrel‐releasing intrauterine system in menorrhagia: a systematic review. British Journal of Obstetrics and Gynecology2001;108(1):74‐86. ">Stewart 2001</a>). Incidence of total adverse events was more likely under danazol treatment. Although acceptability of treatment did not differ between danazol and MFA therapy (50% with danazol versus 47% with MFA refused to continue), the reasons given were not similar. About 80% of this group of danazol‐treated women refused to continue because of adverse effects, but 100% of the MFA group unwilling to continue were unhappy about the lack of efficacy of their treatment. A greater proportion of women in the ethamsylate group compared to women in the NSAID group (MFA) found their treatment unacceptable. </p> </section> <section id="CD000400-sec-0153"> <h4 class="title">Comparison of individual NSAIDs</h4> <p>The clinical differences between individual NSAID preparations have not been previously explored thoroughly in randomised studies. Two studies in this review compared MFA with naproxen and found no differences in post‐treatment MBL or incidence of adverse events, although women treated with MFA were less likely to have gastrointestinal effects. However, this latter finding is based on only one small trial. </p> <p>Although data comparing different types of NSAIDs were limited, there was no suggestion of differential efficacy, so, in line with the widely accepted assumption that NSAIDs have similar clinical efficacy, studies comparing different NSAIDs with placebo or other treatments were combined. </p> </section> <section id="CD000400-sec-0154"> <h4 class="title">Tranexamic acid plus NSAIDs versus tranexamic acid alone</h4> <p>The authors of one trial reported that six months of combined treatment with tranexamic acid plus NSAIDs significantly reduced PBAC scores from baseline, but not treatment with tranexamic acid alone. However the data were in a form that could not be entered into analysis. </p> </section> <section id="CD000400-sec-0155"> <h4 class="title">Overall comparisons</h4> <p>Despite the limited data, it appears that NSAIDs are more effective than placebo but less effective than tranexamic acid, danazol or the LNG IUS in reducing HMB. However, adverse events are more frequent under danazol therapy than NSAID therapy. No trials were identified with data on cost or resource use of NSAID treatments. </p> </section> </section> <section id="CD000400-sec-0156"> <h3 class="title" id="CD000400-sec-0156">Overall completeness and applicability of evidence</h3> <p>Assessment of MBL is difficult because of cycle‐to‐cycle variation in women (<a href="./references#CD000400-bbs2-0040" title="HaynesPJ , HodgsonH , AndersonAB , TurnbullAC . Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology1977;84(10):763‐8. ">Haynes 1977</a>). Haynes and coworkers found that cycle‐to‐cycle variation was greater in women with HMB (39 mL to 271 mL) than in women with normal menses. Consequently, we included trials in this review only if MBL (measured objectively) was greater than 80 mL/cycle for two or more cycles prior to the intervention, although we also included trials where women had a subjective complaint of HMB. The alkaline haematin extraction method is the most commonly used objective method for assessment of blood loss and is used as the standard but a woman's own perception of her MBL is also important in the evaluation of effectiveness of treatment on MBL and as such is also a valid assessment tool. However, many women who seek medical help for HMB will have normal blood loss (<a href="./references#CD000400-bbs2-0030" title="FraserIS , McCarronG , MarkhamR . A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics and Gynecology1984;149:788‐93. ">Fraser 1984</a>; <a href="./references#CD000400-bbs2-0040" title="HaynesPJ , HodgsonH , AndersonAB , TurnbullAC . Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology1977;84(10):763‐8. ">Haynes 1977</a>; <a href="./references#CD000400-bbs2-0056" title="WarnerPE , CritchleyHO , LumsdenMA , Campbell‐BrownM , DouglasA , MurrayGD . Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow up data. American Journal of Obstetrics and Gynecology2004;190:1216‐23. ">Warner 2004a</a>; <a href="./references#CD000400-bbs2-0057" title="WarnerPE , CritchleyHO , LumsdenMA , Campbell‐BrownM , DouglasA , MurrayGD . Menorrhagia II: is the 80‐mL blood loss criterion useful in the management of complaint of menorrhagia?. American Journal of Obstetrics and Gynecology2004;190:1224‐9. ">Warner 2004b</a>), and results from one RCT have suggested that there is little response to therapy in women with MBL less than 35 mL (<a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a>). Since a proportion of the study participants with a complaint of HMB had normal MBL, it is likely that some reported differences between treatment and placebo groups have been underestimated. </p> <p>The studies included in this review examined effects over two or three menstrual cycles of treatment and one study with unpublished data assessed effects one month after treatment was withdrawn. There was no evidence from randomised trials of effects over a longer period but one observational study examined the effects of MFA in 34 women over a 16‐month period and reported persistent reductions of 25% to 35% in MBL and improvement in quality of life (<a href="./references#CD000400-bbs2-0029" title="FraserIS , McCarronG , MarkhamR , RobinsonM , SmythE . Long term treatment of menorrhagia with mefenamic acid. Obstetrics &amp; Gynaecology1983;61:109‐12. ">Fraser 1983</a>). </p> <p>Moreover, different regimens for some of the medical therapies were not considered in the included trials. A longer duration of oral progestogen treatment (from days five to 26 of the menstrual cycle), and longer duration of treatment over a number of cycles with all medical therapies are necessary to assess the comparisons considered in this review adequately. </p> </section> <section id="CD000400-sec-0157"> <h3 class="title" id="CD000400-sec-0157">Quality of the evidence</h3> <p>Although 19 trials met the criteria for inclusion, the inadequacies in some of the studies must be highlighted. The trials were all small and underpowered and for many outcomes the results were based on only one trial. Reduction of MBL in two of the nine trials that were included in the meta‐analysis was correctly reported as a median and range in the publications since the distribution of data was positively skewed with one or more extremely high values (<a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a>; <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a>). Substitution of the mean for the median and the estimation of the SD for these studies has enabled their inclusion in the meta‐analysis but sensitivity analysis with and without the inclusion of <a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a> has not altered results. <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a> was the only trial comparing MBL after treatment with two NSAIDs, MFA and naproxen. The Mann‐Whitney U test reported in the publication of the trial agreed with the results of the meta‐analysis finding no clear evidence of a difference between the groups. </p> <p>Two of the included trials had non‐comparable groups at baseline (<a href="./references#CD000400-bbs2-0003" title="CameronIT . Dysfunctional uterine bleeding. Bailliere's Clinical Obstetrics and Gynaecology1989;2:315‐27. CameronIT , LeaskR , KellyRW , BairdDT . The effects of danazol, mefenamic acid, norethisterone and a progesterone‐impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins1987;34:99‐110. ">Cameron 1987</a>; <a href="./references#CD000400-bbs2-0005" title="ChamberlainG . Comparing treatments for menorrhagia. Nursing Times1992;88:46. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology1991;98:707‐11. ChamberlainG , FreemanR , PriceF , KennedyA , GreenD , EveL . Raw data from RCT. Lorex Synthélabo Laboratory, UK. ">Chamberlain 1991</a>), but sensitivity analysis indicated that their inclusion in the meta‐analysis did not substantially alter the results. </p> <p>Two trials assessed carryover effects (<a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a>; <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a>). <a href="./references#CD000400-bbs2-0007" title="FraserIS , PearseC , ShearmanRP , ElliottPM , McIlveenJ , MarkhamR . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics &amp; Gynaecology1981;58(5):543‐51. ">Fraser 1981</a> was a cross‐over trial of MFA and placebo, and found that the MBL during placebo cycles was greater (but not significantly) in the group that received MFA first. Of considerable interest was the finding that blood loss in the MFA cycles was significantly less when placebo was taken first (P &lt; 0.01), so that MFA appeared to have a greater beneficial effect when taken after placebo. There was evidence of a small carryover effect but this did not reach statistical significance. <a href="./references#CD000400-bbs2-0010" title="HallP , MacLachlanN , ThornN , NuddMW , TaylorCG , GarriochDB . Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology1987;94:554‐8. ">Hall 1987</a> also tested for carryover effects but found none (P = 0.96). It is generally believed that MBL returns to baseline levels very quickly after medical treatment is withdrawn and so the results from the cross‐over trials were unlikely to be affected by carryover effects. </p> </section> <section id="CD000400-sec-0158"> <h3 class="title" id="CD000400-sec-0158">Potential biases in the review process</h3> <p>A comprehensive search for relevant studies minimised the chance of publication bias, but this could not be ruled out. There were too few studies for an analysis of funnel plots to be meaningful. We used appropriate methods to select studies, extract data and make quality assessments, thus minimising the chance of review author error and bias. </p> </section> <section id="CD000400-sec-0159"> <h3 class="title" id="CD000400-sec-0159">Agreements and disagreements with other studies or reviews</h3> <p>The search identified no systematic reviews of NSAIDs. However, evidence‐based guidance from the UK National Institute for Health and Care Excellence (NICE) suggests that NSAIDs, together with tranexamic acid and OCPs, are a recommended second‐line treatment option for women with HMB in whom either hormonal or non‐hormonal treatments are acceptable. For women in whom hormonal treatment is not acceptable, NSAIDs are a first‐line option alongside tranexamic acid (<a href="./references#CD000400-bbs2-0049" title="National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding. guidance.nice.org.uk/CG44/ (accessed 21 November 2012). ">NICE 2007</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000400-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD000400-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000400-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000400-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus placebo, Outcome 1 Menstrual blood loss (MBL) (mL/cycle)." data-id="CD000400-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus placebo, Outcome 1 Menstrual blood loss (MBL) (mL/cycle).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus placebo, Outcome 2 Proportion with no subjective improvement in MBL." data-id="CD000400-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus placebo, Outcome 2 Proportion with no subjective improvement in MBL. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus placebo, Outcome 3 Adverse events." data-id="CD000400-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus placebo, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0007"> <p> <div class="table" id="CD000400-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Mefenamic acid vs placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fraser 1981</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (standard deviation (SD)) on placebo: 70.7 (24.9) mL<br/> Mean menstrual blood loss (SD) on mefenamic acid: 47.3 (21.7) mL<br/> P &lt; 0.001, n = 28, paired t test, t = 6.56<br/> Other outcomes were not given for this subgroup. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Muggeridge 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (SD) on placebo: 161 (78.5) mL<br/> Mean menstrual blood loss (SD) on mefenamic acid: 128.3 (78.1) mL<br/> No significant difference between placebo and mefenamic acid (MFA) cycles, n = 15, Wilcoxon Sum Rank Test </p> <p>Mean score of dysmenorrhoea symptoms (SD) in 2nd placebo cycle: 2.1 (2.1)<br/> Mean score of dysmenorrhoea symptoms (SD) in 2nd MFA cycle: 1.3 (1.6)<br/> No significant difference between placebo and MFA cycles, n = 15, Wilcoxon Sum Rank Test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tsang 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (SD) on placebo: 156.5 (105.9)<br/> Mean menstrual blood loss (SD) on MFA: 140.0 (109)<br/> P &lt; 0.05, n = 10, t test comparing MFA cycles with combined placebo and control cycles </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Naproxen vs placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rybo 1981</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (standard deviation (SD)) on placebo: 144 (26) mL<br/> Mean menstrual blood loss (SD) on naproxen: 107 (154) mL<br/> P &lt; 0.02, n = 4, statistical method not given </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ylikorkala 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (SD) on placebo: 150.7 (34) mL<br/> Mean menstrual blood loss (SD) on naproxen: 96.8 (27.3) mL<br/> P &lt; 0.001, n = 14, paired t test </p> <p>Proportion of women with adverse effects on placebo: 7%<br/> Proportion of women with adverse effects on naproxen: 0%<br/> Not tested </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Ibuprofen vs placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Makarainen 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median menstrual blood loss (range) on placebo: 146 (71–374) mL<br/> Median menstrual blood loss (range) on ibuprofen 600 mg: 123 (23–319) mL<br/> Median menstrual blood loss (range) on ibuprofen 1200 mg: 110 (30–288) mL<br/> P &lt; 0.01, n = 13, Wilcoxon paired test, ibuprofen 1200 vs placebo </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus placebo, Outcome 4 MBL and other outcomes (descriptive results). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0007">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000400-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs versus tranexamic acid, Outcome 1 Menstrual blood loss (MBL) (mL/cycle)." data-id="CD000400-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 1 Menstrual blood loss (MBL) (mL/cycle).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs versus tranexamic acid, Outcome 2 Proportion with no subjective improvement in MBL." data-id="CD000400-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 2 Proportion with no subjective improvement in MBL. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs versus tranexamic acid, Outcome 3 Number of days' bleeding." data-id="CD000400-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 3 Number of days' bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs versus tranexamic acid, Outcome 4 Proportion with no improvement in quality of life or dysmenorrhoea (or both)." data-id="CD000400-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 4 Proportion with no improvement in quality of life or dysmenorrhoea (or both). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs versus tranexamic acid, Outcome 5 Proportion who found treatment unacceptable." data-id="CD000400-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 5 Proportion who found treatment unacceptable. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0013"> <p> <div class="table" id="CD000400-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andersch 1988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean menstrual blood loss (standard deviation (SD)) on tranexamic acid: 154.8 (127.8) mL<br/> Mean menstrual blood loss (SD) on flurbiprofen: 223 (168.5) mL<br/> P &lt; 0.01, n = 15, student's t test </p> <p>Proportion of women with adverse effects on tranexamic acid: 47%<br/> Proportion of women with adverse effects on flurbiprofen: 27%<br/> DIfference not tested </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs versus tranexamic acid, Outcome 6 MBL and other outcomes (descriptive results). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000400-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 1 Menstrual blood loss after treatment (mL/cycle)." data-id="CD000400-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 1 Menstrual blood loss after treatment (mL/cycle). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 2 Menstrual blood loss 1–6 months after treatment (mL/cycle)." data-id="CD000400-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 2 Menstrual blood loss 1–6 months after treatment (mL/cycle). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 3 Proportion with no subjective improvement in MBL." data-id="CD000400-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 3 Proportion with no subjective improvement in MBL. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 4 Proportion with no improvement in quality of life or dysmenorrhoea (or both)." data-id="CD000400-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 4 Proportion with no improvement in quality of life or dysmenorrhoea (or both). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 5 Number of days' bleeding." data-id="CD000400-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 5 Number of days' bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NSAIDs versus ethamsylate, Outcome 6 Proportion who found treatment unacceptable." data-id="CD000400-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 NSAIDs versus ethamsylate, Outcome 6 Proportion who found treatment unacceptable.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NSAIDs versus danazol, Outcome 1 Menstrual blood loss (MBL) (mL/cycle)." data-id="CD000400-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 NSAIDs versus danazol, Outcome 1 Menstrual blood loss (MBL) (mL/cycle).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NSAIDs versus danazol, Outcome 2 Proportion with no improvement in quality of life or dysmenorrhoea (or both)." data-id="CD000400-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 NSAIDs versus danazol, Outcome 2 Proportion with no improvement in quality of life or dysmenorrhoea (or both). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NSAIDs versus danazol, Outcome 3 Number of days' bleeding." data-id="CD000400-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 NSAIDs versus danazol, Outcome 3 Number of days' bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NSAIDs versus danazol, Outcome 4 Proportion who found treatment unacceptable." data-id="CD000400-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 NSAIDs versus danazol, Outcome 4 Proportion who found treatment unacceptable.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NSAIDs versus danazol, Outcome 5 Adverse events." data-id="CD000400-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 NSAIDs versus danazol, Outcome 5 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 1 Menstrual blood loss (MBL) (mL/cycle)." data-id="CD000400-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 1 Menstrual blood loss (MBL) (mL/cycle). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 2 Number of days' bleeding." data-id="CD000400-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 2 Number of days' bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 3 Proportion with non‐adherence." data-id="CD000400-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 3 Proportion with non‐adherence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 4 Total adverse events." data-id="CD000400-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 4 Total adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 5 Adverse events – headache." data-id="CD000400-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 5 Adverse events – headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 6 Adverse events – abdominal pain." data-id="CD000400-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 6 Adverse events – abdominal pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NSAIDs versus oral progestogens, Outcome 7 Adverse events – nausea." data-id="CD000400-fig-0031" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 NSAIDs versus oral progestogens, Outcome 7 Adverse events – nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 1 Menstrual blood loss (MBL) (mL/cycle)." data-id="CD000400-fig-0032" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 1 Menstrual blood loss (MBL) (mL/cycle). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0033"> <p> <div class="table" id="CD000400-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (NSAIDs)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (LNG IUS)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Significance test</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comment</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reid 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menstrual blood loss (alkaline haematin method):<br/> <br/> <br/> <br/> Total menstrual fluid loss:<br/> <br/> <br/> <br/> <br/> PBAC score: </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months:<br/> Median (range): 94 (29–219) mL<br/> 6 months:<br/> Median (range): 100 (46–168) mL<br/> 3 months:<br/> Median (range): 151 (57–280) mL<br/> 6 months:<br/> Median (range): 157 (76–319)<br/> 3 months:<br/> Median (range): 161 (77–262)<br/> 6 months:<br/> Median (range): 159 (50–307) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months:<br/> Median (range): 12 (0‐240) mL<br/> 6 months:<br/> Median (range): 5 (0–45) mL<br/> 3 months:<br/> Median (range): 53 (0–459) mL<br/> 6 months:<br/> Median (range): 27 (0–156) mL<br/> 3 months:<br/> Median (range): 49 (0–286)<br/> 6 months:<br/> Median (range): 25 (0–402) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wilcoxon rank sum test:<br/> P &lt; 0.001 for all comparisons </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 2 MBL and other outcomes (descriptive results). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0033">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000400-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 3 Number of days' bleeding." data-id="CD000400-fig-0034" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 3 Number of days' bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 4 Adverse events." data-id="CD000400-fig-0035" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 NSAIDs versus progesterone‐releasing intrauterine system (IUS), Outcome 4 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 NSAIDs versus oral contraceptive pill (OCP), Outcome 1 Menstrual blood loss (mL/cycle)." data-id="CD000400-fig-0036" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 NSAIDs versus oral contraceptive pill (OCP), Outcome 1 Menstrual blood loss (mL/cycle). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mefenamic acid versus naproxen, Outcome 1 Menstrual blood loss (mL/cycle)." data-id="CD000400-fig-0037" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Mefenamic acid versus naproxen, Outcome 1 Menstrual blood loss (mL/cycle).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mefenamic acid versus naproxen, Outcome 2 Number of days' bleeding." data-id="CD000400-fig-0038" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Mefenamic acid versus naproxen, Outcome 2 Number of days' bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mefenamic acid versus naproxen, Outcome 3 Total adverse events." data-id="CD000400-fig-0039" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Mefenamic acid versus naproxen, Outcome 3 Total adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mefenamic acid versus naproxen, Outcome 4 Gastrointestinal adverse events." data-id="CD000400-fig-0040" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Mefenamic acid versus naproxen, Outcome 4 Gastrointestinal adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/urn:x-wiley:14651858:media:CD000400:CD000400-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_t/tCD000400-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mefenamic acid versus naproxen, Outcome 5 Central nervous system adverse events." data-id="CD000400-fig-0041" src="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Mefenamic acid versus naproxen, Outcome 5 Central nervous system adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/media/CDSR/CD000400/image_n/nCD000400-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000400-fig-0042"> <p> <div class="table" id="CD000400-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline mean PBAC score</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline standard deviation (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PBAC score at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Test</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Najam 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid + mefenamic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>246 points</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 points</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant change from baseline, P &lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Najam 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 points</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>125 points</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not significant change from baseline, P &gt; 0.05</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Tranexamic acid and mefenamic acid versus tranexamic acid, Outcome 1 Pictorial blood loss assessment chart (PBAC) score at 6 months' follow‐up. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-fig-0042">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs versus placebo (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs versus placebo (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>124 lower</b><br/> (186.36 to 61.64 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.08</b> <br/> (0.03 to 0.18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>80<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b><br/> (107 to 419) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b><br/> (107 to 419) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision (very small trial).<br/> <sup>b</sup>Downgraded one level for imprecision (single trial).<br/> <sup>c</sup>Downgraded one level for risk of bias (no explanation was provided). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs versus placebo (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs versus tranexamic acid (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus tranexamic acid (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> tranexamic acid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b><br/> alkaline haematin method </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>73 higher</b><br/> (21.66 to 124.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.44</b> <br/> (0.45 to 4.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>390 per 1000</b><br/> (167 to 672) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b><br/> (167 to 672) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 higher</b><br/> (0.47 lower to 1.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated).<br/> <sup>b</sup>Downgraded one level for imprecision (single trial). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs versus tranexamic acid (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAIDs versus ethamsylate (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus ethamsylate (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> ethamsylate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL at Rx (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL at Rx (mL/cycle) in the intervention groups was<br/> <b>42.88 lower</b><br/> (86.25 lower to 0.5 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of women with no subjective improvement in MBL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.7</b> <br/> (0.23 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>50<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>481 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>394 per 1000</b><br/> (176 to 663) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>482 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>394 per 1000</b><br/> (176 to 664) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 lower</b><br/> (1.56 lower to 0.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug; <b>OR:</b> odds ratio; <b>Rx:</b> treatment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated).<br/> <sup>b</sup>Downgraded one level for imprecision (one small study). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAIDs versus ethamsylate (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">NSAIDs versus danazol (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus danazol (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> danazol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>45.06 higher</b><br/> (18.73 to 71.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>1.03 higher</b><br/> (0.26 to 1.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not stated). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">NSAIDs versus danazol (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">NSAIDs versus oral progestogens (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs vs oral progestogens (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> oral progestogens </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs vs oral progestogens</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>22.97 lower</b><br/> (46.57 lower to 0.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of bleeding (days) in the intervention groups was<br/> <b>0.41 lower</b><br/> (0.95 lower to 0.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">NSAIDs versus oral progestogens (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">NSAIDs versus progesterone‐releasing intrauterine system (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus progesterone‐releasing intrauterine system (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> progesterone‐releasing intrauterine system </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>4 lower</b><br/> (31.23 lower to 23.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>5 lower</b><br/> (6.08 to 3.92 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (randomisation method and allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for imprecision (one small trial). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">NSAIDs versus progesterone‐releasing intrauterine system (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">NSAIDs versus oral contraceptive pill (control)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs versus oral contraceptive pill (control)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> oral contraceptive pill </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAIDs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>25.25 higher</b><br/> (22.34 lower to 72.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Days of bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (randomisation method and allocation concealment not reported).<br/> <sup>b</sup>Downgraded one level for imprecision (one small study). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">NSAIDs versus oral contraceptive pill (control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000400-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Mefenamic acid compared to naproxen for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Mefenamic acid compared to naproxen for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with heavy menstrual bleeding<br/> <b>Intervention:</b> mefenamic acid<br/> <b>Comparison:</b> naproxen </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Naproxen</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Mefenamic acid </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MBL (mL/cycle)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MBL (mL/cycle) in the intervention groups was<br/> <b>21 higher</b><br/> (5.85 lower to 47.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of days' bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of menstruation (days) in the intervention groups was<br/> <b>0.4 lower</b><br/> (1.59 lower to 0.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MBL:</b> menstrual blood loss; <b>NSAID:</b> non‐steroidal anti‐inflammatory drug. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (lack of blinding).<br/> <sup>b</sup>Downgraded one level for imprecision (one or two small studies).<br/> <sup>c</sup>Downgraded one level for risk of bias (attrition bias). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Mefenamic acid compared to naproxen for heavy menstrual bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/full#CD000400-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (MBL) (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐124.0 [‐186.36, ‐61.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐124.0 [‐186.36, ‐61.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion with no subjective improvement in MBL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.03, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.03, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.07, 8.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.07, 8.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 MBL and other outcomes (descriptive results) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Ibuprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAIDs versus tranexamic acid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (MBL) (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>73.0 [21.66, 124.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion with no subjective improvement in MBL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.45, 4.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.47, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Proportion with no improvement in quality of life or dysmenorrhoea (or both) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.27, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Proportion who found treatment unacceptable <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.32, 4.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 MBL and other outcomes (descriptive results) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAIDs versus tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NSAIDs versus ethamsylate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss after treatment (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐42.88 [‐86.25, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Menstrual blood loss 1–6 months after treatment (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐70.3 [‐158.88, 18.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion with no subjective improvement in MBL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.23, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Proportion with no improvement in quality of life or dysmenorrhoea (or both) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.18, 3.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.56, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Proportion who found treatment unacceptable <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NSAIDs versus ethamsylate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NSAIDs versus danazol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (MBL) (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>45.06 [18.73, 71.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion with no improvement in quality of life or dysmenorrhoea (or both) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.20, 7.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.26, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Proportion who found treatment unacceptable <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.24, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.05, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NSAIDs versus danazol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">NSAIDs versus oral progestogens</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (MBL) (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.97 [‐46.57, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐0.95, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion with non‐adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.05, 14.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.13, 2.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events – headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.14, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events – abdominal pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.15, 4.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events – nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.17, 18.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">NSAIDs versus oral progestogens</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">NSAIDs versus progesterone‐releasing intrauterine system (IUS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (MBL) (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.0 [‐31.23, 23.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 MBL and other outcomes (descriptive results) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.0 [‐6.08, ‐3.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.31, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.06, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Ovarian cyst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.10, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Breast pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.07, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [0.37, 10.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.53 [0.57, 21.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Upper respiratory infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.24, 3.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">NSAIDs versus progesterone‐releasing intrauterine system (IUS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">NSAIDs versus oral contraceptive pill (OCP)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>25.25 [‐22.34, 72.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">NSAIDs versus oral contraceptive pill (OCP)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Mefenamic acid versus naproxen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Menstrual blood loss (mL/cycle) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.00 [‐5.85, 47.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of days' bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.59, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Total adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Gastrointestinal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.06, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Central nervous system adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.34, 5.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Mefenamic acid versus naproxen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000400-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Tranexamic acid and mefenamic acid versus tranexamic acid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pictorial blood loss assessment chart (PBAC) score at 6 months' follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Tranexamic acid and mefenamic acid versus tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000400.pub4/references#CD000400-tbl-0017">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000400.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000400-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000400-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000400-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hu#CD000400-note-0018">Magyar</a> </li> <li class="section-language"> <a class="" href="ko#CD000400-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000400-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD000400-note-0001">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000400-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000400\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000400\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000400\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000400\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000400\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000400.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000400.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000400.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000400.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000400.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717229490"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000400.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717229494"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000400.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db2d6cee09365',t:'MTc0MDcxNzIyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 